This invention relates generally to storage containers for medical devices, and more particularly to a storage container for a long, flexible medical implement, such as a catheter, and related medical devices, as well as an instruction manual included therewith.
Medical devices, including surgical instruments, supplies, and so forth, are generally shipped from manufacturer to medical services provider in sterile packaging. For example, a scalpel may be shipped to a surgeon in a plastic, vacuum-sealed, sterile package. Similarly, bandages may be shipped in paper, plastic, or paper composite sterile wrappers. When the medical services provider is ready to use the medical supply, the sterile package is removed. The medical services provider then uses the object in accordance with the procedure being performed.
While conventional packaging works well for objects having a generally unchanging form factor, special considerations have to be taken into consideration for some medical supplies. By way of example, catheter assemblies and other flexible equipment is generally shipped in a coiled configuration. Once the sterile packaging is removed, the catheter must be uncoiled prior to use. Care must be taken in shipping, unwrapping, and using the catheter. For instance, if a catheter is inadvertently bent, kinked, or otherwise damaged, it may no longer be suitable for use. Compounding this issue, catheters are available in a variety of lengths ranging from 100 centimeters to over 250 centimeters.
Traditional catheters are packaged, for example, in individual packaging. The catheter and card are then sealed in a sterile plastic wrap. These catheters are prone to damage in shipment, storage, and when being unpacked, as the card and wrap provide little physical protection.
Some manufacturers have started shipping catheters and other similar devices in flat plastic trays. For example, U.S. Pat. No. 6,068,121 to McGlinch teaches one such tray. The tray has several specifically contoured loops such that one universal tray will accommodate several different sized catheters. Such packaging presents a problem, however, in that large amounts of storage space are taken with a universal tray, especially when a relatively short catheter is shipped therein. Additionally, when in use, these trays occupy large amounts of a medical service provider's sterile workspace or table, leaving little room for related components, such as lubricants, fluid bags, and so forth.
There is thus a need for an improved container for flexible medical devices or catheters that facilitates more effective and simpler deployment of the device during a procedure.
The accompanying figures, where like reference numerals refer to identical or functionally similar elements throughout the separate views and which together with the detailed description below are incorporated in and form part of the specification, serve to further illustrate various embodiments and to explain various principles and advantages all in accordance with the present invention.
Skilled artisans will appreciate that elements in the figures are illustrated for simplicity and clarity and have not necessarily been drawn to scale. For example, the dimensions of some of the elements in the figures may be exaggerated relative to other elements to help to improve understanding of embodiments of the present invention.
Embodiments of the invention are now described in detail. Referring to the drawings, like numbers indicate like parts throughout the views. As used in the description herein and throughout the claims, the following terms take the meanings explicitly associated herein, unless the context clearly dictates otherwise: the meaning of “a,” “an,” and “the” includes plural reference, the meaning of “in” includes “in” and “on.” Relational terms such as first and second, top and bottom, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, reference designators shown herein in parenthesis indicate components shown in a figure other than the one in discussion. For example, talking about a device (10) while discussing figure A would refer to an element, 10, shown in figure other than figure A.
Embodiments of the present invention provide a medical procedure kit that includes medical products for performing a medical procedure. In one embodiment, the medical procedure kit is configured for a catheterization procedure. Such an embodiment will be used herein for illustration purposes. However, it will be clear to those of ordinary skill in the art having the benefit of this disclosure that embodiments of the invention are not so limited. Other medical procedure kits for performing other procedures could be substituted for the illustrative catheterization tray disclosed herein by substituting other medical implements for the catheterization implements. In the illustrative embodiment, a tray is configured to accommodate a medical device or assembly. In an illustrative embodiment, the medical device is a coiled device, such as a catheter or catheter assembly. In addition to accommodating the coiled medical device, embodiments of the present invention are also configured to contain devices and materials intended for use with the coiled medical device.
Using a catheter assembly as an example, when a catheter assembly is inserted into a patient, sterile water may be used to inflate the catheter. Additionally, the catheter may be coated in a lubricating jelly prior to insertion into the patient. Fluids and other samples may then be monitored and obtained from the patient via the catheter. Embodiments of the present invention provide a single container configured to accommodate not only the catheter assembly and fluid bag, but also syringes containing sterile water or lubricants. Further, the tray can accommodate a sterile specimen jar for capturing samples taken from the patient via the catheter.
In addition to simply accommodating these corresponding medical devices, in one embodiment the tray is configured to provide the medical services provider with mnemonic devices instructing them in which order to use each device. For example, a compartment containing syringes, in one embodiment, includes an inclined, stair-stepped bottom member to present the plungers of each syringe at an easy to reach angle and at different heights based upon order of use.
Another advantage of embodiments of the present invention is that compartments have multi-purpose functionality. For example, in one embodiment, a container configured to accommodate a syringe having lubricating jelly disposed therein is also configured to be used as a lubricating jelly applicator. A medical services provider first dispenses the lubricating jelly into the syringe compartment. The medical services provider then passes the catheter from another compartment through an opening in a barrier separating the compartments into the lubricating jelly. As such, the tray not only serves as a shipping and storage container for an assembly of devices used with a catheter procedure, but also as an application device to assist a medical services provider in using those products together.
Turning now to
The tray 100, in one embodiment, is formed by a contoured surface 104 that defines the various features and compartments of the tray 100. The contoured surface 104 of the tray 100 can be manufactured in various ways. For example, in one embodiment, the tray 100 can be thermally formed on a mold from a soft thermoplastic, such as styrene or polystyrene. In another embodiment, the tray 100 can be injection molded. In another embodiment, the tray can be poured on a mold using a quick setting plastic, epoxy, or resin. Other methods of manufacture will be obvious to those of ordinary skill in the art having the benefit of this disclosure.
Exemplary dimensions for one embodiment of the tray 100 are as follows: The length 112 can be between nine and twelve inches, such as ten inches. One illustrative length 112 may be 10.380 inches. Similarly, the width 113 can be between eight and eleven inches, such as nine inches. One illustrative width 113 is 9.250 inches. The height 114 can be between one and three inches. One illustrative height 114 is 1.750 inches.
In one embodiment, the tray 100 includes three main compartments: a first compartment 101, a second compartment 102, and a third compartment 103. The first compartment 101 is separated from the second compartment 102 by a first barrier 105. The second compartment 102 is separated from the third compartment 103 by a second barrier 106.
In one embodiment, the compartments are open from the top of the tray 100—the top being opposite the base members of the tray 100—and are bounded on the bottom by a first base member 107, a second base member 108, and a third base member 109. The compartments are bounded on the sides by a perimeter wall 110. In the illustrative “open top” embodiment of
In one illustrative embodiment, the tray 100 is configured to hold or otherwise accommodate all of the necessary devices and materials to perform a catheter-based procedure on a patient. Said differently, the tray 100 is configured to hold not only the catheter assembly, but the medical devices corresponding to catheter use as well. Using one illustrative procedure as an example, the following devices will be used: a syringe holding sterile water, a syringe holding lubricating jelly or another equivalent lubricant, a catheter assembly, skin cleansing or preparation materials, and a specimen jar. The various compartments and features of the tray 100 shown in
In one embodiment suitable for procedures using the syringe holding sterile water, syringe holding lubricating jelly, catheter assembly, and specimen jar, in one embodiment, the tray 100 is configured such that these objects are ordered in accordance with their use during the procedure. For example, in one embodiment the tray 100 includes a first compartment 101 for accommodating one or more syringes, a second compartment 102 for accommodating the catheter assembly, and a third compartment 103 for accommodating the specimen jar. These devices stowed in the various compartments will be illustrated and described with respect to
For example, in one embodiment the first compartment base member 107 includes a stair-stepped contour 115 suitable for accommodating a plurality of syringes at different heights. For example, a first step portion 116 of the stair-stepped contour 115 may be at a different height within the tray 100 than a second step portion 117 of the stair-stepped contour. In the illustrative embodiment of
The stair-stepped contour 115 can be used as mnemonic device when multiple syringes are stored within the first compartment 101. For example, it may be intuitive that a syringe placed on a higher step portion may need to be used first. This intuition is further enforced when the higher step portion is disposed farther to the left in a left-to-right usage configuration. Thus, a user receives a mnemonic reminder to use a syringe disposed on the first step portion 116 prior to a syringe disposed on the second step portion 117, as it is both higher and farther to the left.
Where syringes are stowed in the first compartment 101, the first compartment base member 107 can further be configured for syringe ease of use. For example, in one embodiment the first compartment base member 107 is inclined relative to other compartment base members. In the illustrative embodiment of
In this illustrative embodiment, however, the first compartment base member 107 is configured to be inclined relative to one or both of the second compartment base member 108 and third compartment base member 109. As such, the stair-stepped contour 115 forms a ramp upon which syringes may be placed so that the plunger of each syringe is predisposed to project upward and out of the tray 100. Said differently, the stair-stepped contour 115 is configured such that the first step portion 116 and the second step portion 117 are disposed in a non-parallel orientation relative to the second compartment base member 108. This configuration makes it easier for a medical services provider to grasp the syringes and remove them from the tray 100.
The first compartment base member 107 may include other features suitable for accommodating one or more syringes as well. In one embodiment, one or both of the first step portion 116 and second step portion 117 include recesses 118,119 for accommodating a syringe flange. These recesses 118,119 generally function to prevent the syringes from sliding lengthwise within the first compartment 101. Similarly, in one embodiment one or both of the first step portion 116 and the second step portion 117 include protrusions 120 that help to prevent the syringes from sliding laterally within the first compartment 101.
In one embodiment, one or both of the first barrier 105 and the second barrier 106 include openings disposed therein. In the illustrative embodiment shown in
While the opening depths can be the same, in one embodiment the opening depths are different. For example, in the illustrative embodiments of
For instance, in many catheter procedures a pair of syringes—such as syringes having a one-half inch diameter—fits easily into the first compartment 101 when the tray 100 is made with the illustrative dimensions set forth above. However, some procedures require one or more of the syringes to be larger. For example, some syringes are larger in diameter. These larger syringes are capable of nesting within the first opening 121 and second opening 122. The inclined opening side members prevent the syringe from moving lengthwise, while the disparate opening heights present the plunger of the syringe to the medical services provider for easy removal from the tray 100.
The stair-stepped contour 115, working in tandem with the first opening 121, gives the tray additional advantages over prior art catheter containers. For instance, when the first compartment 101 has a first compartment base member 107 configured with a stair-stepped contour 115, the first compartment 101 can be used as a lubricant applicator for the catheter.
Specifically, the medical services provider may dispense the lubricating jelly along the second step portion 117. As the second step portion 117 is lower in the tray 100 than the first step portion 116, the second step portion 117 serves as a channel in which the lubricating jelly may spread. A medical services provider may then pass the catheter through the first opening 121, through the channel formed by the second step portion 117, i.e., along the second step portion 117 through the dispensed lubricating jelly, and out the top of the tray 100 to the patient. This feature of the tray 100 greatly eases the application of lubricating jelly to the catheter when compared to prior art solutions. In one embodiment, the tray 100 is packaged with printed instructions showing the medical services provider how to apply lubricating jelly in this manner. The printed instructions will be described in more detail below with respect to
It will be clear to those of ordinary skill in the art having the benefit of this disclosure that alternative methods may be used to apply the lubricating jelly as well. For example, in another embodiment, the lubricating jelly is dispensed directly onto the catheter tubing while the tubing is in or above the first compartment 101. Excess lubricant falling from the catheter tubing can then collect, and be retained, in the second step portion 117.
This particular feature highlights another advantage of the “compartmentalized” structure of various embodiments of the invention. As the tray 100 includes multiple compartments, various tasks associated with a catheterization procedure can be completed while keeping the catheter within the tray 100. The ability to keep the catheter in the tray 100 reduces the risk that the catheter or corresponding devices will be contaminated with bacteria or microbes on other objects within the procedure room. For example, when the first compartment 101 is used to apply lubricating jelly to the catheter, the lubricating jelly can be applied while the catheter is contained within the tray 100, thereby reducing the risk that the catheter will become contaminated. This correspondingly reduces the risk of infection for the patient receiving the catheter.
Prior art systems, for example such as those in which the catheterization procedure components are shipped in separate containers, may contribute to substandard techniques in that the catheter can become contaminated when moving it from its shipping container. Consequently, the patient can be at an elevated risk of infection as the catheter is moved from one tray to another. Embodiments of the present invention solve this problem by providing a single level tray 100 with compartments. Further, in one embodiment the first compartment 101 includes the first opening 121 so the catheter can stay in place during and after lubrication. By having easy access to the components disposed in the single level tray 100, the medical services provider can more easily prepare and use the components within the tray 100. This helps to minimize the risk of contaminating the patient or the sterile field during the procedure.
In one embodiment, the second step portion 117 is configured to be inclined at a shallower angle than the first step portion 116 in at least a portion opposite the recess 119 from the first opening 121. When configured in such a fashion, the second step portion 117 includes a “cutdown” so that the catheter can stay within the channel both during and after lubrication.
Additionally, the catheter can be placed in both the first opening 121 and second opening 122 during lubrication. When positioned in this configuration, the second opening 122 helps to align the catheter with the first opening for easy passage through the lubrication channel formed by the second step portion 117.
The tray 100 of
Another advantage of the tray 100 is that its compartmentalized configuration helps to reduce the risk of contaminating a patient or compromising the sterile nature of the components stored in the tray 100. Since both the catheter assembly and medical devices corresponding to catheter use are stored within the same tray 100, the risk of cross-contamination between sterile work areas and non-sterile spaces is minimized. Further, by having the catheter assembly and the devices corresponding to catheter use stowed in a one-level tray rather than a multi-level, stacked configuration, the medical services provider can more easily prepare and use the catheter and corresponding devices disposed within the tray 100.
Turning now to
The illustrative catheter packaging system of
As noted above, in one embodiment the flange 111 can include instructions 770 or other graphical indicia. As also noted above, the implements disposed in the various compartments 101,102,103 can have implements therein arranged in accordance with use. In one embodiment, shown illustratively in
As illustrated in
Syringes 701,702 are disposed in the first compartment, with one syringe 701 being supported at a different elevation within the tray than the other syringe 702. The different elevations can be relative to each syringe 701,702, or to other components of the tray 100, such as the second compartment base member 108. Said differently, one syringe 701 is supported by the first compartment base member 107 at a shallower depth within the tray 100 than the depth of the second compartment base member 108. Further, where the first compartment base member 107 is inclined relative to other base members, one or both syringes 701,702 will be supported in a non-parallel configuration relative to the second compartment base member 108. This is most readily seen in
As noted above, some medical procedures will call for more materials than can be accommodated by a syringe capable of fitting within the first compartment 101. For such procedures, the tray 100 can be packed with larger syringes. A large syringe (not shown) can be supported laterally within the tray 100 when it is placed across the tray 100 such that it lies within both the first opening 121 of the first barrier 105 and the second opening 122 of the second barrier 106. Such a syringe will pass across the top of the catheter assembly 700, but will be held in place by the side members of each opening.
Turning now to
Once the necessary components are disposed within the tray 100, the tray can be sealed with a wrap 1000 to keep the internal components sterile. The wrap 1000 can be any of a number of types of material. In one embodiment, the wrap 1000 comprises a Central Sterile Reprocessing (CSR) wrap that is used widely by medical professionals in hospitals, ambulatory surgical centers, and the like during medical procedures. While a CSR wrap is one example of a wrap that can be used, it will be clear to those of ordinary skill in the art that other wraps, such as plastic, cotton, linen, paper, or combinations thereof, can be substituted without departing from the spirit and scope of the invention.
Using a CSR wrap as an illustrative example, in one embodiment as indicated in
Printed instructions 1001 can then be attached to, disposed upon, or disposed within the tray 100. In one embodiment, the printed instructions 1001 include a health care services portion and a patient portion, as will be shown in
The patient portion can include helpful suggestions or instructions for the patient. The patient portion can be detachably coupled to the health care services portion, such as by a perforated line that is easily torn to separate the patient portion from the health care services portion. Examples of suggestions or instructions that may be included in the patient portion include information on what a catheter is, what the patient should understand about the catheter, how to reduce the chance of getting an infection, information about infections commonly associated with catheters, symptoms of infections commonly associated with catheters, and suggestions for home use of the catheter assembly 700. In one embodiment, the health care services portion may include an instruction for the health care services provider to detach the patient portion from the health care services portion and instructions to discuss the patient portion with the patient.
The health care services portion can tell the medical services provider how to perform a standard catheterization procedure. For instance, in one embodiment, the tray 100 is equipped with an adhesive label that can be used to identify the patient or specimen in the specimen container 703. Further, a label can be included to mark or otherwise identify the material in the fluid bag attached to the catheter. Such labels can include pre-printed fields, such as date, time and name. Further the printed instructions 1001 can notify the medical services provider that the devices disposed within the tray 100 are ordered corresponding to use during the catheterization procedure.
In another embodiment, the printed instructions 1001 can inform the medical services provider of special instructions. For instance, in one embodiment the printed instructions 1001 can inform the medical services provider not to leave a catheter in a patient for more than forty-eight hours without a physician's approval. Where the printed instructions 1001 include such information, the labels included in the tray 100 may have pre-printed fields for the time of insertion that can be filled in by the medical services provider performing the catheterization procedure.
Once the printed instructions 1001 have been affixed to, or placed with, within, or atop the tray 100, the assembly can be sealed in a sterile wrap 1002 such as a thermally sealed bag. The thermally sealed bag can optionally include a preformed opening. For example, in one embodiment, the opening can include one or more tabs that a health care services provider is instructed to pull to open the bag. Inclusion of a sterile wrap 1002 not only keeps the contents within the bag sterile, but also allows the instructions to be included with the tray assembly, yet outside the CSR wrap 1000.
In one embodiment the printed instructions 1001 are disposed atop the CSR wrap 1000 such that the health care services portion of the printed instructions 1001 is disposed on the top of the printed instructions 1001, with the patient portion being disposed adjacent to the CSR wrap 1000, such as when the printed instructions 1001 are configured as an accordion-style folded instruction pamphlet. While the printed instructions 1001 of one embodiment are configured as a folded, printed, separate article disposed atop the CSR wrap 1000, it will be clear to those of ordinary skill in the art having the benefit of this disclosure that the invention is not so limited. For example, in one embodiment the sterile wrap 1002 can be optional. In one embodiment, rather than including separate printed instructions 1001, the instructions for use can be printed on the CSR wrap 1000 as well.
Additional instruction materials may be included with the completed assembly as well. For example, in one embodiment an adhesive instruction tag 1003 can be affixed to the sterile wrap 1002. In another embodiment the instruction tag may be adhered to an outer packaging, that encloses the tray, the sterile wrap material or both. For example, in one embodiment the instruction tag 1003 can include information regarding whether a catheter procedure is needed. Text 1004 such as “Is there a valid clinical reason?” may be included under an instruction to “Stop” that includes the following information:
Further, checklist text 1005 may be included, such as “Checklist for Foley Catheter Insertion” included under the word “Check” that includes the following information:
Additional information may also be included, such as a fillable form 1006 that provides fields for the date and time of insertion of the catheter to be recorded, the name of the health care services provider, and the signature of the health care services provider. The above text 1004 for the instruction tag 1003 is illustrative only, and may be customized as desired by the manufacturer.
Turning now to
Once the tray (100) is procured, the manufacturer can dispose at least one syringe (701) in the first compartment (101) at step 1102. Optionally, at step 1103, the manufacturer may include additional components with the tray (100). For example, a catheter securement device, a Foley insert tag, or other complementary components may be included at this step 1103.
In one embodiment, as determined at decision 1105, a second syringe (702) will be disposed in the first compartment (101) at step 1106. In another embodiment, the second syringe (702) will be disposed laterally within the first opening (121) and, where present, a second opening (122) at step 1107.
At step 1104, the manufacturer will place the catheter assembly (700) in the second compartment (102). Other components may be disposed in the tray (100) as well, including a specimen container (703) that is disposed in a third compartment (103) at step 1108. Further, other devices may be included, such as towels, drapes, printed instructions, one or more antiseptic packets, and so forth. These other devices can be disposed in various compartments within the tray (100).
At step 1109, the tray (100) is sealed. This can be accomplished by folding a CSR wrap about the tray (100). In such an embodiment, the CSR wrap can be used during the catheter insertion procedure as well. At optional step 1110, the manufacturer can enclose printed instructions (1001). In one embodiment, the printed instructions (1001) will direct a user to discharge contents of at least one syringe into the first compartment (101) and to pass at least a portion of the catheter assembly (700) through the opening and into the contents to lubricate the catheter.
At step 1111, the manufacturer can place a sterile wrap about the tray (100) and the printed instructions (1001), where included. A sticker or other sealing device can be applied that indicates the contents to be sterile as well. At step 1112, the completed assembly can be shipped to a medical services provider.
Turning now to
Beginning with
At this step, the catheter assembly 700 is placed within the first compartment 101 as previously described. The tray is then placed upon one or more layers of wrap material 2200. In one embodiment, the wrap material 2200 can be CSR wrap. For example, in the illustrative embodiment of
While the tray 100 can be sealed with a simple layer of plastic adhered to the top of the tray 100, providing the wrap material 2200 can be advantageous in many applications. For example, as will be explained below with respect to
Note that for reference and ease of explanation, the tray 100 will be described as having four sides: a first side 2201, a second side 2202, a third side 2203, and a fourth side 2204. As these sides will not be visible in every view, due to the folding of the wrap material 2200 about the tray 100, they are initially noted here. Note that four sides are used because the illustrative tray 100 is rectangular in shape. Were the tray a triangle, there would be three sides. Were the tray ovular or circular, there would be an infinite number of sides.
Turning now to
Turning to
Turning now to
In the illustrative embodiment of
Turning now to
Turning now to
Turning now to
The one or more layers of wrap material 2200 and the additional layer of wrap material 2701 can be the same type of material. Alternatively, the one or more layers of wrap material 2200 and the additional layer of wrap material 2701 can be different. In one embodiment, for example, the additional layer of wrap material 2701 can be a fenestrated wrap with one or more pre-formed openings suited to the catheterization procedure.
In one embodiment, the additional layer of wrap material 2701 is configured to be visibly distinguishable from the one or more layers of wrap material 2200. For example, in one embodiment, the additional layer of wrap material 2701 is a different color than the one or more layers of wrap material 2200. The one or more layers of wrap material 2200 can be white, for instance, while the additional layer of wrap material 2701 can be light blue or light green. Other color combinations can equally be used.
As with the package of liquid hand sanitizer 2401 and package of rubber gloves 2402, in one embodiment the additional layer of wrap material 2701 can be placed atop portions of the one or more layers of wrap material 2200. In such an embodiment, the additional layer of wrap material 2701 can be held in place by way of subsequent folding steps, as the additional layer of wrap material 2701 is disposed along other folded portions of the one or more layers of wrap material 2200 prior to folding a fourth portion of the one or more layers of wrap material about the fourth side (2204) of the tray (100).
As will be shown below, medical procedure kits configured in accordance with embodiments of the invention can include printed instructions. The printed instructions can include a patient portion and a health care services provider portion. The health care services provider portion can include information such as how to use the medical procedure kit, what is included therein, checklists, and so forth. The patient portion can include helpful information for the patient, such as information about the procedure, questions to ask, and post procedure care suggestions. These two portions can be detachably coupled together. Alternatively, they can be separate.
In one embodiment of the invention where the health care services portion of the printed instructions are physically separated from the patient portion, it can be advantageous to stage the various portions at different locations within the assembled medical procedure kit. One advantage offered by embodiments of the invention is that the medical devices and implements can be staged within the kit in accordance with an order of use. Accordingly, the health care services provider can draw out each device in order of use.
Turning now briefly to
In
The package of liquid hand sanitizer 2401 and package of rubber gloves 2402, optionally the additional layer of material 2701, and the separated health care services portion 3401 of the printed instructions can be placed atop portions of the one or more layers of wrap material 2200. In such an embodiment, the package of liquid hand sanitizer 2401, the rubber gloves 2402, the additional layer of material 2701, and the separated health care services portion 3401 can be held in place by way of subsequent folding steps, as they are disposed along other folded portions of the one or more layers of wrap material 2200 prior to folding a fourth portion of the one or more layers of wrap material about the fourth side (2204) of the tray (100). Accordingly, the health care services provider will be readily able to access these devices after unfolding a single fold of the one or more layers of wrap material 2200.
Turning now to
Turning briefly to
The separated patient portion 3501 is then placed atop the fourth portion 2801. The health care services provider is therefore able to access the separated patient portion 3501 and deliver it to, and possibly discuss it with, a patient prior to unfolding the fourth portion 2801. The step of tucking shown in
Turning now to
Turning briefly to
Prior to depositing the packaged catheter assembly 2901 into the bag 2902, the separated patient portion 3501 of the optional printed instructions can be attached to or disposed upon the packaged catheter assembly 2901 as described in
Once the printed instructions 1001 have been affixed to, or placed with or atop the packaged catheter assembly 2901, as in either
Turning back to
Turning now to
Another difference in the embodiment of
Beginning with
Once the necessary components are disposed within the tray 100, the tray can be enclosed with a wrap 1000. The wrap 1000 can be one or more layers in number, and further can be any of a number of types of material. In one embodiment, the wrap 1000 comprises a CSR wrap.
Using a CSR wrap as an illustrative example, in one embodiment as indicated in
Printed instructions can then be attached to, disposed upon, or disposed within the tray 100. In the illustrative embodiment of
In the embodiment of
In one embodiment, the health care services portion 3802 includes a peelable flap 3803. By pulling back the peelable flap 3803, the health care services portion 3802 opens to reveal instructions and other information therein. For example, in one embodiment, the interior of the health care services portion 3802 can include one or more of the panels shown in
The patient portion 3801 can include helpful suggestions or instructions for the patient. The patient portion 3801 can be configured as a greeting card to make the information more pleasantly received by a patient. Examples of suggestions or instructions that may be included in the patient portion include information on what a catheter is, what the patient should understand about the catheter, how to reduce the chance of getting an infection, information about infections commonly associated with catheters, symptoms of infections commonly associated with catheters, and suggestions for home use of the catheter assembly 700.
In the embodiment of
The package of liquid hand sanitizer and package of rubber gloves described above (not shown in
The health care services portion 3802 can be affixed to the packaging 3804. The packaging 3804 can optionally include a preformed opening. For example, in one embodiment, the opening can include one or more tabs that a health care services provider is instructed to pull to open the packaging 3804.
Turning now to
Turning now to
In one embodiment, the printed instructions 1001 are configured as a two-portion instruction manual having a health care services portion 1201 and a patient portion 1202. In the illustrative embodiment of
In one embodiment, the printed instructions 1001 are configured as a plurality of panels 1204,1205,1206,1301,1302,1303. As will be shown in
In one embodiment, the health care services portion 1201 includes instructions 1304 for using the catheter assembly and other corresponding medical devices disposed within the accompanying tray. The instructions 1304 can include text and/or figures or illustrations showing how to use the catheter assembly and corresponding medical devices on the patient, as well as instructions on preparation, taking samples, preventing infection, and so forth. The instructions 1304, in one embodiment, also include an instruction to detach the patient portion 1202, give the patient portion 1202 to the patient, as well as an instruction to discuss the information disposed on the patient portion 1202 with the patient.
Similarly, the patient portion 1202 may also include instructions 1305 and/or helpful suggestions for the patient who is undergoing the catheterization procedure. For instance, this information can include any one or more of the following: a description of what a catheter is, what the patient should know about the catheter, how to reduce the chance of getting an infection from the catheterization procedure, what infections commonly associated with catheterization procedures typically are, the symptoms associated with infections commonly associated with catheterization procedures, and information about using the catheter at home. Additionally, the patient portion 1202 may include custom information as well. For example, in one embodiment the patient portion 1202 includes an informational section configured such that the health care service provider's name and contact information can be written thereon. It will be clear to those of ordinary skill in the art having the benefit of this disclosure that the invention is not so limited. For example, additional types of health care service instructions or patient instructions or suggestions can also be included.
Turning now to
Beginning with
Panel 1204 can include general information about the catheter assembly and corresponding medical devices disposed within the tray. For example, this information can include part number information 1401, trade name information 1402, and manufacturer information 1403. A diagram 1404 of the contents of the package assembly may be included as well. The illustrative diagram 1404 of
In addition to a diagram 1404, panel 1204 can also include a written description 1407 of the elements included in the tray 100. Further, sterility information 1407 can be included. Panel 1204 can even include instructional material 1406 on how to use the instruction manual as well.
Turning now to
Panel 1301 can include instructions for using the catheter assembly and the corresponding medical devices. As can be seen from this illustrative embodiment, panel 1301 can include instructions for setting up a clean work area. The instructions can include text, pictures, illustrations, or combinations of these.
In one embodiment, the instructions for setting up a clean work area include a hygiene performance step 1501, which may include instructions to wash hands, optionally put on gloves (which at this step can be non-sterile gloves), and so froth. The instructions may then include information on opening the remainder of the catheter package assembly. For instance, in
Step 1503 then instructs the health care provide to pick up the underbuttocks of the patient and to place the underbuttocks wrap beneath the patient. Step 1504 then instructs the health care provider to use the hand sanitizing solution provided with the catheter package assembly.
As with other panels shown in
In addition to information for setting up a clean work area, in one embodiment panel 1301 includes instructions for preparing the catheter assembly (700) as well. For example, step 1506 instructs the health care services provider to don sterile gloves, as the hands were sanitized at step 1504. Step 1507 tells the health care services provider to place the fenestrated drape with a shiny side down on the patient without contaminating the sterile gloves donned at step 1506. Step 1508 instructs the health care services provider to test the balloon of the catheter assembly with the water-filled syringe stored in the first compartment. Step 1508 also instructs the health care services provider to leave the syringe connected to the catheter assembly.
Step 1509 then provides instructions on using the first compartment of the tray as a lubricant application chamber as described above. Specifically, in this illustrative embodiment, step 1509 instructs the health care services provider to inject the lubricating jelly found in the second syringe of the first compartment into the first compartment. Step 1509 also instructs the health care services provider to pass the tip of the catheter through the first opening in the wall separating the first compartment and second compartment into the lubricating jelly, thereby lubricating the tip of the catheter.
Turning now to
At step 1601, the instructions direct the health care services provider to tear open the swab stick package and to use the swab sticks to clean the patient from the top down. The instruction also notes that each swab stick is intended for one use only to properly maintain the sterile field. Step 1602 directs the health care services provider to initiate the catheterization process by inserting the catheter assembly into the patient. Steps 1603 and 1604 continue this process as shown in
Step 1605 directs the health care services provider to secure the drainage bag to the catheter assembly. Step 1606 directs the health care services provider to clean up upon completion of the catheterization process. Step 1607 provides instructions on completing the label on the Foley insertion tag included with the catheter package assembly and attaching it to the tubing or drain bag attached to the catheter assembly.
At step 1608, the health care services provider is instructed to detach the patient portion (1202) from the health care services portion (1201) by tearing the two apart along the perforation (1203). Step 1609 further instructs the health care services provider to discuss the patient information printed upon the patient portion (1202) with the patient. Step 1609 instructs that documentation of the entire procedure should be completed.
Turning now to
The panel 1303 also includes information 1703 regarding how the patient can reduce the chances of getting an infection. This information 1703 can include a statement that the patient should wash their hands prior to touching the catheter assembly. The information 1703 may also include a statement that the drainage bag should always be kept at a level beneath the patient's navel, and that the patient should inform a helper when the bag is more than half full.
Turning to
By way of example, information 1801 informs the patient as to what common infections associated with catheter use are and how they are contracted. Information 1802 provides symptoms of these common infections, such as fever, blood in the urine, burning or painful urination, or frequent or more urgent urination after catheter removal. Information 1803 informs the patient of what they should know prior to going home after a catheter procedure.
Information 1804 comprises an informational section configured such that a health care provider's name and contact information may be written thereon. This is helpful to the patient in the event that the symptoms recited in information 1802 should arise after the procedure, in that the patient has readily available access to the information required to contact a physician or other health care provider. An advantage of having this information 1804 on the patient portion (1202) when the patient portion (1202) is detachable is that the patient can take it with them upon completion of the procedure.
Turning now to
Turning now to
In
Turning now to
In the embodiment of
A flap indicator 4005 indicates that more information is located within the printed instructions 4000. The additional information, which can be one or more of the panels shown in
The checklist 4002 can be configured as described above. In the embodiment of
Turning now to
The interior of the patient portion 3801 can include text. For example, in one embodiment where the patient portion 3801 is to be included with a catheter assembly, the interior includes the following illustrative text:
Here is some simple information about foley catheterization:
1. What is a Urinary Catheter?
A thin flexible tube that drains urine from the bladder into a collection bag. The catheter helps:
When you can't urinate.
To measure how much urine you're producing.
During and after some surgeries or tests.
2. What should you know about your catheter?
Only a trained technician inserts a catheter when necessary, and it is removed as soon as possible.
Caregivers must wash hands with soap or use alcohol-based rubs before and after touching your catheter.
If your caregivers don't clean their hands, politely ask them to.
Do not disconnect the catheter yourself.
Inquire every day whether you still need the catheter.
3. What is ‘catheter-associated’ urinary tract infection (CAUTI)?
If a catheter introduces ‘outside’ germs into your urinary tract, they can cause an invention. If a UTI is acquired, you may experience:
Sudden fever and/or bloody urine.
Burning or painful urination, or pain below the stomach.
Frequent, or more urgent, urinating after catheter is removed.
Tell your provider right away. An antibiotic may be needed.
4. Can you reduce your chances of an infection? Absolutely!
Wash your hands before and after touching your catheter.
Make sure the tube is secured to your leg. Never twist, or tug on it.
Always keep the collection bag below the level of your belly button.
Do not disconnect the catheter yourself.
Ask your doctor every day whether you still nee the catheter.
The above information on the patient portion 3801 can be printed in multiple languages, such as in Spanish or in English. Where two languages are used, the back portion may be the same as the image shown in
Turning now to
At step 2102, the health care services provider accesses the printed instructions (1001) and begins to read the panels, which in one embodiment are panels configured in accordance with those described in
At step 2103, the health care services provider unfolds the outer CSR wrap (1000), which in one embodiment is then used to create a sterile field about the tray (100). At step 2104, the health care services provider prepares the workspace, which in one embodiment may be in accordance with steps (1501,1502,1503,1504) of panel (1301) in
At step 2105, the health care services provider prepares the catheter, which in one embodiment may be in accordance with steps (1506,1507,1508,1509) of panel (1301) as described in
At step 2106, the health care services provider inserts the catheter. In one embodiment, this can be in accordance with steps (1601,1602,1603,1604) of panel (1302) as described in
At step 2108, the health care services provider detaches the patient portion (1202) of the printed instructions (1001) from the health care services portion (1201). In one embodiment, this occurs by tearing the patient portion (1202) from the health care services portion (1201) along the perforation (1203), thereby transforming the printed instructions (1001) or instruction manual from a singular or unitary object into a two-piece object consisting of the patient portion (1202) and the health care services portion (1201). As described, above, the health care services provider may then discuss the patient portion (1202) with the patient and further give the patient portion (1202) to the patient to take home after the procedure.
Turning now to
The health care services provider 3101 can then unfold the one or more layers of wrap material 2200. Where an additional layer of wrap material 2701 is included, this unfolding step reveals and makes accessible the additional layer of wrap material 2701. Note that portions of the additional layer of wrap material 2701 may be visible, as shown in
As noted above, in one embodiment the one or more layers of wrap material 2200 can be unfolded to form a sterile field. Turning now to
Turning now to
In the foregoing specification, specific embodiments of the present invention have been described. However, one of ordinary skill in the art appreciates that various modifications and changes can be made without departing from the scope of the present invention as set forth in the claims below. Thus, while preferred embodiments of the invention have been illustrated and described, it is clear that the invention is not so limited. Numerous modifications, changes, variations, substitutions, and equivalents will occur to those skilled in the art without departing from the spirit and scope of the present invention as defined by the following claims. Accordingly, the specification and figures are to be regarded in an illustrative rather than a restrictive sense, and all such modifications are intended to be included within the scope of present invention. The benefits, advantages, solutions to problems, and any element(s) that may cause any benefit, advantage, or solution to occur or become more pronounced are not to be construed as a critical, required, or essential features or elements of any or all the claims.
This application is a continuation application claiming priority to Ser. No. 16/833,575, filed Mar. 28, 2020, which is a continuation application claiming priority to Ser. No. 15/684,787, filed Aug. 23, 2017, which is a continuation application claiming priority to Ser. No. 14/793,455, filed Jul. 7, 2015, which is a continuation application claiming priority to Ser. No. 13/860,902, filed Apr. 11, 2013, which is a divisional application from Ser. No. 13/155,026, filed Jun. 7, 2011, which claims priority and benefit under 35 U.S.C. § 119(e) from U.S. Provisional Applications: Ser. No. 61/352,140, filed Jun. 7, 2010; Ser. No. 61/352,155, filed Jun. 7, 2010; Ser. No. 61/428,944, filed Dec. 31, 2010; and Ser. No. 61/437,796, filed Jan. 31, 2011, each of which is incorporated herein by reference. Moreover, Ser. No. 13/155,026 is further a continuation in part of: Ser. No. 12/495,148, filed Jun. 30, 2009, which claims priority and bent under 35 U.S.C. § 119(e) from U.S. Provisional Application: Ser. No. 61/183,629, filed Jun. 3, 2009; Ser. No. 12/647,515, filed Dec. 27, 2009; Ser. No. 13/153,265, filed Jun. 3, 2011; and Ser. No. 13/153,300, filed Jun. 3, 2011, each of which is incorporated herein by reference. As the present application claims priority to Ser. No. 13/155,026 through Ser. No. 14/793,455 and Ser. No. 13/860,902, the present application also, by law, claims priority to each of Ser. No. 12/495,148, Ser. No. 12/647,515, Ser. No. 13/153,265, and Ser. No. 13/153,300 through its priority claim to Ser. No. 13/155,026. This application is related to commonly assigned U.S. Pat. No. 7,624,869 to Primer, which is incorporated herein by reference. This application is related to commonly assigned U.S. patent application Ser. No. 12/004,796, filed Dec. 21, 2007, which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2659485 | Duley et al. | Nov 1953 | A |
2715296 | Petit | Aug 1955 | A |
2781611 | West | Feb 1957 | A |
2886316 | Ayala | May 1959 | A |
2947415 | Garth | Aug 1960 | A |
2954642 | Roderick | Oct 1960 | A |
2959891 | Barnett et al. | Nov 1960 | A |
3013656 | Murphy, Jr. | Dec 1961 | A |
3107786 | Adelman | Oct 1963 | A |
3133635 | Morris | May 1964 | A |
3166189 | Disston | Jan 1965 | A |
3315802 | Maro | Apr 1967 | A |
3329261 | Serany, Jr. et al. | Jul 1967 | A |
D209641 | Goldberg | Dec 1967 | S |
3379339 | Asenbauer | Apr 1968 | A |
3485352 | Pilger | Dec 1969 | A |
D218077 | Gabriel | Jul 1970 | S |
3542019 | Gittins | Dec 1970 | A |
3650393 | Reiss | Mar 1972 | A |
3726281 | Norton | Apr 1973 | A |
3770119 | Hultberg et al. | Nov 1973 | A |
3851649 | Villari | Dec 1974 | A |
D234404 | Merril | Feb 1975 | S |
3901235 | Patel et al. | Aug 1975 | A |
D237315 | Nowkowski | Oct 1975 | S |
D237317 | Nowkowski | Oct 1975 | S |
3965900 | Boedecker | Jun 1976 | A |
3967728 | Gordon et al. | Jul 1976 | A |
3976195 | Cohen | Aug 1976 | A |
3978983 | Brezetta | Sep 1976 | A |
D242654 | Rawls | Dec 1976 | S |
3998221 | Collins | Dec 1976 | A |
D243798 | Swartz | Mar 1977 | S |
4011944 | Cooley | Mar 1977 | A |
4053280 | Salisbury | Oct 1977 | A |
4075782 | Neuschatz | Feb 1978 | A |
4085845 | Perfect | Apr 1978 | A |
D248871 | Forsman et al. | Aug 1978 | S |
D249362 | Forsman et al. | Sep 1978 | S |
4140127 | Ciani et al. | Feb 1979 | A |
4160505 | Rauschenberger | Jul 1979 | A |
4170300 | Pick | Oct 1979 | A |
4226328 | Beddow | Oct 1980 | A |
4266669 | Watson | May 1981 | A |
4269310 | Uson | May 1981 | A |
4282678 | Tsui | Aug 1981 | A |
4307539 | Klein | Dec 1981 | A |
D262995 | Gaba et al. | Feb 1982 | S |
4334537 | Peterson | Jun 1982 | A |
D268130 | Easton | Mar 1983 | S |
4411656 | Cornett | Oct 1983 | A |
4439184 | Wheeler | Mar 1984 | A |
4458705 | Cawood | Jul 1984 | A |
4460360 | Finegold | Jul 1984 | A |
D275886 | Sheward et al. | Oct 1984 | S |
D276462 | Villarreal | Nov 1984 | S |
D277508 | Clair | Feb 1985 | S |
4501363 | Isbey, Jr. | Feb 1985 | A |
4523679 | Paikoff et al. | Jun 1985 | A |
4530349 | Metzger | Jul 1985 | A |
D280663 | Albon et al. | Sep 1985 | S |
D280933 | McLaughlin | Oct 1985 | S |
D280993 | Mariol | Oct 1985 | S |
4554156 | Fischer | Nov 1985 | A |
D283051 | Fichera | Mar 1986 | S |
D287760 | Discko, Jr. | Jan 1987 | S |
4761008 | Huggins | Aug 1988 | A |
4767008 | Warnecke et al. | Aug 1988 | A |
4795441 | Bhatt | Jan 1989 | A |
4811847 | Reif | Mar 1989 | A |
4828113 | Friedland | May 1989 | A |
4844259 | Glowczewskie et al. | Jul 1989 | A |
4858821 | Bickelhaupt | Aug 1989 | A |
4925448 | Bazaral | May 1990 | A |
4928830 | Brewer | May 1990 | A |
D310896 | Winjum | Sep 1990 | S |
4991877 | Lieberman | Feb 1991 | A |
5007535 | Meseke et al. | Apr 1991 | A |
5024326 | Sandel et al. | Jun 1991 | A |
5031768 | Fischer | Jul 1991 | A |
5094621 | Friedel | Mar 1992 | A |
5163557 | Sokolowski | Nov 1992 | A |
5170804 | Glassman | Dec 1992 | A |
5197885 | Friedel | Mar 1993 | A |
D334973 | Valentine et al. | Apr 1993 | S |
D337830 | Coyne et al. | Jul 1993 | S |
5232369 | Mavrikis | Aug 1993 | A |
5242398 | Knoll et al. | Sep 1993 | A |
5244394 | Serabian-Musto | Sep 1993 | A |
D343687 | Houghton et al. | Jan 1994 | S |
5289919 | Fischer | Mar 1994 | A |
5312287 | Chuang | May 1994 | A |
5314339 | Aponte | May 1994 | A |
5318543 | Ross et al. | Jun 1994 | A |
5324201 | Friedel | Jun 1994 | A |
5339955 | Horan et al. | Aug 1994 | A |
D351661 | Fischer | Oct 1994 | S |
5392918 | Harrison | Feb 1995 | A |
5411437 | Weber et al. | May 1995 | A |
5487566 | Hedge, Jr. | Jan 1996 | A |
D380272 | Partika et al. | Jun 1997 | S |
5665945 | Oshima | Sep 1997 | A |
D387177 | Davis | Dec 1997 | S |
D387559 | Williamson | Dec 1997 | S |
5713778 | Rodeosevich et al. | Feb 1998 | A |
5720502 | Cain | Feb 1998 | A |
5778574 | Reuben | Jul 1998 | A |
5779053 | Partika | Jul 1998 | A |
5795213 | Goodwin | Aug 1998 | A |
5810738 | Thomas, II | Sep 1998 | A |
5820441 | Pracas | Oct 1998 | A |
5827262 | Neftel et al. | Oct 1998 | A |
5829790 | Phillips | Nov 1998 | A |
5872262 | Dolle, III et al. | Feb 1999 | A |
5887749 | Schommer | Mar 1999 | A |
5931303 | Salvadori | Aug 1999 | A |
5941241 | Weinstein et al. | Aug 1999 | A |
5947284 | Foster | Sep 1999 | A |
5954369 | Seabrook | Sep 1999 | A |
5975295 | Diamond | Nov 1999 | A |
6004136 | Ehrenpreis | Dec 1999 | A |
6012586 | Misra | Jan 2000 | A |
6068121 | McGlinch | May 2000 | A |
6089943 | Lo | Jul 2000 | A |
6142152 | Gawarecki | Nov 2000 | A |
6158437 | Vagley | Dec 2000 | A |
6159017 | Coomansingh | Dec 2000 | A |
D442697 | Hajianpour | May 2001 | S |
D450130 | Goldstein | Nov 2001 | S |
D450391 | Hunt et al. | Nov 2001 | S |
6330427 | Tabachnik | Dec 2001 | B1 |
6361396 | Snyder et al. | Mar 2002 | B1 |
6382212 | Borchard | May 2002 | B1 |
6405863 | Dhindsa | Jun 2002 | B1 |
6454097 | Blanco | Sep 2002 | B1 |
6579271 | Aruffo et al. | Jun 2003 | B1 |
6659506 | Erisalu | Dec 2003 | B1 |
6681933 | Demsien et al. | Jan 2004 | B1 |
6769546 | Busch | Aug 2004 | B2 |
D495491 | Ramirez | Sep 2004 | S |
6793078 | Roshdy | Sep 2004 | B2 |
6840379 | Franks-Farah et al. | Jan 2005 | B2 |
6896141 | McMichael et al. | May 2005 | B2 |
6915901 | Feinberg | Jul 2005 | B2 |
6926708 | Franks-Farah et al. | Aug 2005 | B1 |
6948742 | Buck | Sep 2005 | B2 |
7048120 | Pond | May 2006 | B2 |
7066328 | Pulsifer | Jun 2006 | B2 |
D530920 | Snell | Oct 2006 | S |
D547064 | Snell | Jul 2007 | S |
D549454 | Ahman | Aug 2007 | S |
7264869 | Tobita | Sep 2007 | B2 |
7278987 | Solazzo | Oct 2007 | B2 |
D557047 | Dretzka | Dec 2007 | S |
D561473 | Phillips et al. | Feb 2008 | S |
D563673 | Dretzka | Mar 2008 | S |
7401703 | McMichael | Jul 2008 | B2 |
7434687 | Itou et al. | Oct 2008 | B2 |
D579662 | Dretzka | Nov 2008 | S |
D590596 | Dretzka | Apr 2009 | S |
D596311 | Antons | Jul 2009 | S |
7624869 | Primer | Dec 2009 | B2 |
D609819 | Tomes et al. | Feb 2010 | S |
D612153 | Liao | Mar 2010 | S |
7785312 | Thorne | Aug 2010 | B2 |
D623765 | Tomes et al. | Sep 2010 | S |
7789873 | Kubalak | Sep 2010 | B2 |
D636894 | Tomes et al. | Apr 2011 | S |
D638137 | Gross et al. | May 2011 | S |
D650912 | Tomes et al. | Dec 2011 | S |
D662218 | Pittman | Jun 2012 | S |
8448786 | Tomes et al. | May 2013 | B2 |
D688461 | Ambrefe et al. | Aug 2013 | S |
8628549 | To et al. | Jan 2014 | B2 |
8631935 | Tomes et al. | Jan 2014 | B2 |
8678190 | Tomes et al. | Mar 2014 | B2 |
8708999 | Hong et al. | Apr 2014 | B2 |
D704856 | Tomes et al. | May 2014 | S |
D708347 | Lober | Jul 2014 | S |
D708759 | Heyman et al. | Jul 2014 | S |
D720470 | Lober | Dec 2014 | S |
D720471 | Angel et al. | Dec 2014 | S |
9084593 | Yakel et al. | Jul 2015 | B2 |
D742028 | Hutchison | Oct 2015 | S |
9283352 | Tomes et al. | Mar 2016 | B2 |
9522753 | Tomes et al. | Dec 2016 | B2 |
D779082 | Andre et al. | Feb 2017 | S |
9693756 | Tomes | Jul 2017 | B2 |
9745088 | Tomes | Aug 2017 | B2 |
D800337 | Daines | Oct 2017 | S |
9795761 | Lockwood et al. | Oct 2017 | B2 |
9808400 | Tomes et al. | Nov 2017 | B2 |
9808596 | Tomes | Nov 2017 | B2 |
D832456 | Self | Oct 2018 | S |
10251812 | Tomes et al. | Apr 2019 | B2 |
10512752 | Tomes | Dec 2019 | B2 |
10640243 | Tomes et al. | May 2020 | B2 |
10946169 | Lockwood | Mar 2021 | B2 |
10946992 | Tomes | Mar 2021 | B2 |
20020185406 | Massengale | Dec 2002 | A1 |
20030031995 | Laura | Feb 2003 | A1 |
20030038475 | Stancil | Feb 2003 | A1 |
20030075474 | Moyer et al. | Apr 2003 | A1 |
20030159966 | McMichael et al. | Aug 2003 | A1 |
20030159969 | McMichael et al. | Aug 2003 | A1 |
20040004019 | Busch | Jan 2004 | A1 |
20040031721 | Mann | Feb 2004 | A1 |
20040055919 | Rowe et al. | Mar 2004 | A1 |
20040161732 | Stump | Aug 2004 | A1 |
20040180822 | Grafton | Sep 2004 | A1 |
20040195145 | Roshdy | Oct 2004 | A1 |
20040238391 | Pond | Dec 2004 | A1 |
20050022822 | Santilli | Feb 2005 | A1 |
20050101905 | Merry | May 2005 | A1 |
20050228691 | Paparo | Oct 2005 | A1 |
20050241986 | Massengale et al. | Nov 2005 | A1 |
20050256453 | Nagamatsu | Nov 2005 | A1 |
20050285385 | Bova | Dec 2005 | A1 |
20060009742 | Solazzo | Jan 2006 | A1 |
20060011501 | Itou | Jan 2006 | A1 |
20060011506 | Riley | Jan 2006 | A1 |
20060029912 | Kearby et al. | Feb 2006 | A1 |
20060088355 | Ribi | Apr 2006 | A1 |
20060096877 | Khajavi et al. | May 2006 | A1 |
20060186010 | Warnack | Aug 2006 | A1 |
20060264822 | Nagamatsu | Nov 2006 | A1 |
20060271019 | Stoller | Nov 2006 | A1 |
20070026472 | Prokash et al. | Feb 2007 | A1 |
20070060908 | Webster et al. | Mar 2007 | A1 |
20070065792 | Schubarth | Mar 2007 | A1 |
20070084742 | Miller et al. | Apr 2007 | A1 |
20070088330 | House | Apr 2007 | A1 |
20070095699 | Frieze | May 2007 | A1 |
20070142786 | Lampropoulos | Jun 2007 | A1 |
20070161971 | House | Jul 2007 | A1 |
20070197998 | Itou | Aug 2007 | A1 |
20070203464 | Green et al. | Aug 2007 | A1 |
20070225687 | House | Sep 2007 | A1 |
20070299431 | Jakubowski et al. | Dec 2007 | A1 |
20080116106 | Lampropoulos et al. | May 2008 | A1 |
20080121553 | Gobel | May 2008 | A1 |
20080125722 | Hess | May 2008 | A1 |
20080221515 | Nagamatsu | Sep 2008 | A1 |
20080249476 | Bierman et al. | Oct 2008 | A1 |
20080281254 | Humayun et al. | Nov 2008 | A1 |
20080283426 | Primer et al. | Nov 2008 | A1 |
20080283433 | Primer | Nov 2008 | A1 |
20090004055 | Darrigrand et al. | Jan 2009 | A1 |
20090071854 | Martin | Mar 2009 | A1 |
20090099531 | Griesbach, III | Apr 2009 | A1 |
20090152160 | Thompson et al. | Jun 2009 | A1 |
20090184026 | Massengale et al. | Jul 2009 | A1 |
20090194453 | Thorne et al. | Aug 2009 | A1 |
20090234346 | McBride et al. | Sep 2009 | A1 |
20090236259 | Hicks | Sep 2009 | A1 |
20090301927 | Fvlbrook | Dec 2009 | A1 |
20090318783 | Rohde et al. | Dec 2009 | A1 |
20100272669 | Malessa | Oct 2010 | A1 |
20100274205 | Morelli et al. | Oct 2010 | A1 |
20100307941 | Tomes et al. | Dec 2010 | A1 |
20100307942 | Tomes et al. | Dec 2010 | A1 |
20100311026 | Tomes et al. | Dec 2010 | A1 |
20110017621 | Zoland | Jan 2011 | A1 |
20110107494 | Haines | May 2011 | A1 |
20110155599 | Yakel et al. | Jun 2011 | A1 |
20110218520 | Andrich | Sep 2011 | A1 |
20110225726 | Dominguez | Sep 2011 | A1 |
20110232234 | Lockwood et al. | Sep 2011 | A1 |
20110233079 | Macinnes et al. | Sep 2011 | A1 |
20110284410 | Lockwood | Nov 2011 | A1 |
20110290260 | Tomes et al. | Dec 2011 | A1 |
20110290262 | Tomes et al. | Dec 2011 | A1 |
20110297147 | Lick et al. | Dec 2011 | A1 |
20120145589 | Macinnes et al. | Jun 2012 | A1 |
20120267272 | Agrawal | Oct 2012 | A1 |
20140110296 | Terzibashian | Apr 2014 | A1 |
20170202699 | Zani et al. | Jul 2017 | A1 |
20170216558 | Hughett et al. | Aug 2017 | A1 |
20170368302 | Brooks | Dec 2017 | A1 |
20190344044 | Dickinson et al. | Nov 2019 | A1 |
Number | Date | Country |
---|---|---|
6012586 | Jan 2000 | CA |
201823147 | May 2011 | CN |
2007045943 | Apr 2007 | EP |
2000281144 | Oct 2000 | JP |
2002068309 | Mar 2002 | JP |
2007-229520 | Sep 2007 | JP |
2005027767 | Mar 2005 | WO |
2006114466 | Nov 2006 | WO |
2007045943 | Apr 2007 | WO |
Entry |
---|
Medline Industries Inc. vs C.R Bard. Inc., Exhibit G to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016. |
Chinese Application No. 201280035240.4; Filed May 24, 2012; Mailed Aug. 18, 2015. |
Dictionary definition m-w. URL:<http://ww.merriam-webster.com/dictionary/reassure>. Retrieved from Internet Dec. 10, 2013. |
Dictionary definition m-w. URL:<http://www.merriam-webster.com/dictionary/brave>. Retrieved fro Internet Dec. 10, 2013. |
Inter Partes Review—Patent Owner's Prelim. Response; U.S. Pat. No. 9,795,761; Inter Partes Review No. IPR2019-00109; Filed Feb. 22, 2019. |
Inter Partes Review—Patent Owner's Prelim. Response; U.S. Pat. No. 9,808,400; Inter Partes Review No. IPR2019-00208; Filed Mar. 7, 2019. |
IPR Petition 2001, Declaration of Meyst dated Jan. 11, 2019; IPR 2019-00035, IPR-2019-00036. |
IPR Petition 2002, Declaration of Weintraub dated Jan. 11, 2019; IPR 2019-00035, IPR-2019-00036. |
IPR Petition Exhibit 2001, Declaration of Meyst dated Feb. 22, 2019; IPR2019-00109. |
IPR Petition Exhibit 2001, Declaration of Meyst dated Mar. 7, 2019; IPR2019-00208. |
IPR Petition Exhibit 2001; Declaration of Meyst dated Mar. 7, 2019; IPR2019-00223. |
IPR Petition Exhibit 2002, Declaration of Weintraub dated Mar. 7, 2019; IPR2019-00208. |
IPR Petition Exhibit 2002, Declaration of Weintraub dated Mar. 7, 2019; IPR2019-00223. |
Lion King Sticker website. URL: <http://tlkobession.wuffpaws.org/OldSite/games/games2.html>. 1996 Retrieved from Internet Dec. 10, 2013. |
Lion Sticker Activity Book website. URL: <http://www.amazon.com/Disneys-Simbas-Pride-Sticker-Activity/dp/B0018DOJZA>. 1998 Retrieved from Internet Dec. 10, 2013. |
Medline Industries Inc. vs C.R Bard, Inc., Exhibit 1 to Declaration of Karl L. Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018. |
Medline Industries Inc. vs C.R Bard, Inc.. Exhibit A lo Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.. Exhibit A to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Bnef; Civil Action No. t:14-cv-03618: Judge John Z. Lee; Filed Aug. 15, 2016. |
Medline Industries Inc. vs C.R Bard, Inc: Exhibit F to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1.17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018. |
Medline Industries Inc. vs C.R Bard. Inc., Exhibit 4 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R Bard. Inc., Exhibit C to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman. Filed Jan. 12, 2018. |
Medline Industries Inc. vs C.R Bard. Inc.. Exhibit 3 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman. Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R Bard. Inc.; Exhibit C to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 116-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017. |
Medline Industries Inc. vs C.R Bard. Inc.; Exhibit F to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman: Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit E to Declaration of Nicole Smith in Support of Bard Reply lo Claim Construction Brief; Civil Action No. 1.16-cv-03529. Judge Sharon Johnson Coleman. Filed Jan. 12, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc; Exhibit A (List of Invalidating Prior Art) to C R. Bard's LPR 2 3 Contentions; Civil Action No. t:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018. |
Medline Industries inc. vs C R. Bard, Inc; Exhibit E to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Feb. 27, 2018. |
Medline industnes Inc, vs C.R Bard, Inc.; Exhibit A to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John 2. Lee: Filed Jun. 4, 2016. |
Medline industnes Inc. vs C R. Bard, Inc; C.R Bard's LPR 2 3 Contentions; Civil Action No. 1:17-cv-7216, Judge Sara L. Ellis; Filed Jan. 16, 2018. |
Medline Industnes Inc. vs C R. Bard, Inc; Declaration oi Nicole M Smith in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:14-cv-03618: Judge John 2. Lee; Filed Jun. 4, 2016. |
Medline industnes Inc. vs C R. Bard, Inc; Exhibit B to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv7216; Judge Sara L. Ellis; Filed Feb. 27, 2018. |
Medline Industnes inc. vs C R. Bard, Inc; Exhibit D to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis: Filed Feb. 27, 2018. |
Medline Industnes Inc. vs C.R Bard, Inc.; Exhibit G to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John 2, Lee; Filed Jun. 4, 2016. |
Medline Industnes Inc. vs C.R Bard, Inc.; Exhibit H to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jun. 4, 2016. |
Medline Industnes Inc. vs C R. Bard, Inc; Exhibit A—C R. Bards Second Amended Answer to Second Amended Complaint: Civil Action No. 1:!7-cv-7216; Judge Sara L Ellis; Filed Feb. 27, 2018. |
Medline Industries Inc. vs C.R Bard, Inc., Declaration of Barbara Weintraub re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017. |
Medline industries Inc. vs C.R Bard, Inc., Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017. |
Medline Industries Inc. vs C.R Bard, Inc., Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017. |
Medline Industries Inc. vs C.R Bard, Inc., Exhibit 1 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R Bard, Inc., Exhibit 2 lo Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R Bard, Inc., Exhibit 7 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard, Inc., Exhibit A to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1;16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016. |
Medline Industries Inc. vs C.R Bard, Inc., Exhibit A to Declaration of Kevin A. Lake. Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard, Inc., Exhibit B to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman: Filed Dec. 9, 2016. |
Medline industries Inc. vs C.R Bard, inc., Exhibit F to Declaration of Dyian J. Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016. |
Medline Industries Inc. vs C.R Bard, Inc., Exhibit F to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017. |
Medline Industries Inc. vs C.R Bard, Inc., Exhibit H to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.. Bard Opening Claim Construction Bnef; Civil Action No. 1 16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.. Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief: Civil Action No. I:14-cv-03518; Judge John 2. Lee; Fiied Aug. 15, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.. Exhibit 1 to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.. Exhibit 10 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.. Exhibit 2 to Declaration of Brian Eutermoser in Support of Medline Surrepiy: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Sep. 7, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.. Exhibit C to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman: Filed Nov. 11, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.. Exhibit E to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017. |
Medline Industries Inc. vs C.R Bard, Inc.. Exhibit I to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.. Exhibit i to Declaration of Nicoie M. Smith, Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jun. 4, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Bard Reply to Medline Claim Construction Brief; Civil Action No. 1 I6-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017. |
Medline Industries Inc. vs C.R Bard, Inc.; C. R. Bard's Reply in Support of Claim Construction Brief; Civil Action No. 1.14-cv-03618, Judge John Z. Lee; Filed Aug. 15, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Karl L Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:16-CV-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018. |
Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Karl L. Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1.14-cv-03618. Judge John Z. Lee; Filed Aug. 15, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Richard Meyst re Claim Construction; Civil Action No. 1.16-cv-03529. Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 1 to Declaration of Karl L Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1.14-cv-03618; Judge John Z. Lee, Filed Aug. 15, P016. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 1 to Declaration of Karl R Leinsing in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 3 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee, Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 4 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit A to Declaration of Barbara Weintraub re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman. Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit B to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 1;16-cv-03529. Judge Sharon Johnson Coleman. Filed Jan. 12, 2018. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit B to Declaration ot Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Aug. 15, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit C to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1:14-cv 03618; Judge John Z. Lee; Filed Aug. 15, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit D to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit D to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief: Civil Action No. 1.14-cv-03618; Judge John Z. Lee. Filed Aug. 15, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit D to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman Filed Jan. 27, 2017. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit E to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618, Judge John Z. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit F lo Declaration of Kevin A Lake: Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit F to Declaration of Dylan J. Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1. I4-CV-03618; Judge John Z. Lee, Filed Aug. 15, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit G to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit G to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief: Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Jan. 27, 2017. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit H to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit H to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief. Civil Action Mo. 1:16-cv-Q3529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit I to Declaration of Kevin A. Lake; Civil Action No. 1.14-sv-03618; Judge John 2. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit N to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Medline Memo of Law re Expert Testimony in Claim Construction Proceedings; Civil Action No. 1;14-cv-03618; Judge John Z. Lee. Filed Jan. 25, 2017. |
Medline industries Inc. vs C.R Bard, Inc.; Medline Surreply to Claim Construction Bnef; Civil Action No. 1.14-CV-Q3618: Judge John Z. Lee; Filed Sep. 7, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Transcript of Deposition ot Richard Meyst; Civil Action No. 1:16-W-03529. Jan. 20, 2017. |
Medline Industries Inc. vs C.R Bard, Inc: Exhibit G to C.R Bard's LPR 2.3 Contentions; Civil Action No. 1.17-cv-7216; Judge Sara L Ellis; Fiied Jan. 16, 2013. |
Medline Industries Inc. vs C.R Bard, Inc; Exhibit 3 to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-CV-7216; Judge Sara L Ellis; Filed Jan. 16, 2018. |
Medline Industries Inc. vs C.R Bard, Inc; Exhibit C to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018. |
Medline Industries Inc. vs C.R Bard, Inc; Exhibit D to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Etlis; Filed Jan. 16, 2018. |
Medline Industries Inc. vs C.R Bard, Inc; Exhibit E to C R. Bard's LPR 2.3 Contentions; Civil Action No. 1;17-cv-7216; Judge Sara L. Ellis; Fiied Jan. 16, 2018. |
Medline Industries Inc. vs C.R Bard. Inc, Exhibit H loC.R. Bard's LPR 2.3 Contentions. Civil Action No. 1:17-CV-7216; Judge Sara L. Ellis: Filed Jan. 16, 2018. |
Medline industries Inc. vs C.R Bard. Inc., Declaration of Brian Eutermoser in Support of Medline Surreply. Civil Action No. 1:14-cv-03618, Judge John Z. Lee; Filed Sep. 7, 2016. |
Medline Industries Inc. vs C.R Bard. Inc., Exhibit 8 lo Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618: Judge John Z. Lee: Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard. Inc., Exhibit A to Declaration of Barbara Weintraub Regarding Claim Construction: Civil Action No. 1.14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard. Inc., Exhibit A to Declaration of Nicole Smith in Support of Bard Repiy lo Medline Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017. |
Medline Industries Inc. vs C.R Bard. Inc., Exhibit B to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016. |
Medline Industries Inc. vs C.R Bard. Inc., Exhibit E to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1.14-cv-03618; Judge John Z. Lee, Filed Aug. 15, 2016. |
Medline Industries Inc. vs C.R Bard. Inc.. Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard. Inc.. Exhibit 11 to Declaration of Richard Meyst re Claim Construction: Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R Bard. Inc.. Exhibit A to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1;14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard. Inc.. Medline Motion lo Supplement Record on Claim Construction with Leinsing Testimony; Civil Action No. 1:14-w-03618; Judge John Z. Lee; Filed Mar. 23, 2017. |
Medline Industries Inc. vs C.R Bard. Inc.; Bard Reply Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018. |
Medline Industries Inc. vs C.R Bard. Inc.; Bard Response to Memo of Law re Expert Testimony in Claim Construction Proceedings; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Feb. 8, 2017. |
Medline Industries Inc. vs C.R Bard. Inc.; Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction Brief. Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017. |
Medline Industries Inc. vs C.R Bard. Inc.; Declaration of Karl R. leinsing in Support of Bard Reply io Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017. |
Medline Industries Inc. vs C.R Bard. Inc.; Exhibit 3 to Declaration of Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618: Judge John Z. Lee. Filed Mar. 23, 2017. |
Medline Industries Inc. vs C.R Bard. Inc.; Exhibit 8 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R Bard. Inc.; Exhibit C to Declaration of Kevin A. Lake; Civil Action No. 1 14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard. Inc.; Exhibit G to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017. |
Medline Industries Inc. vs C.R Bard. Inc.; Exhibit G to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline industries Inc. vs C.R Bard. Inc.; Exhibit H to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017. |
Medline Industries Inc. vs C.R Bard. Inc.; Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 2016. |
Medline Industries Inc. vs C.R Bard. Inc.; Transcript of Deposition of Barbara A Weinlraub; Civil Action Mo. 1:16-cv-03529; Jan. 20, 2017. |
Medline Industries Inc. vs C.R Bard. Inc.; Transcript of Deposition of Karl Leinsing; Civil Action No. 1:16-cv-03529; Feb. 17, 2017. |
Medline industries Inc. vs C.R Sard, Inc.; Exhibit 9 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc., Bard Response to Medline Surreply re Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Sep. 13, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc., Exhibit 2 to Declaration of Karl L. Lansing in Support of Bard's Rebuttal on Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Aug. 15, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc., Exhibit B to Declaration of Kevin A. Lake. Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc., Exhibit D to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 116-cv-03529; Judge Sharon Johnson Coleman. Filed Jan. 12, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc., Exhibit J to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc., Exhibit Kto Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc.. Exhibit 1 to Declaration of Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Mar. 23, 2017. |
Medline Industries Inc. vs C.R. Bard, Inc.. Exhibit 9 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc.. Exhibit L to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman: Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc.. Medline Response to Bard Claim Construction Brief. Civil Action No. 1:14˜cv-03618: Judge John Z. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc.: Exhibit 2 to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 117-CV-7216; Judge Sara L Eiiis; Filed Jan. 16, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Barbara Weintraub re Claim Construction: Civil Action No. 1.16-cv-03529. Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 10 lo Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 2 to Declaration of Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Mar. 23, 2017. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 5 to Declaration of Richard Meyst re Claim Construction: Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman, Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 6 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman. Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 7 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit C to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit E to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit M to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R. Bard. Inc., Exhibit 2 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618; Judge John 2. Lee. Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R. Bard. Inc.; Exhibit 5 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R. Bard. Inc.; Exhibit 6 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Jul. 8, 2016. |
Medline industries Inc. vs C.R. Bard. Inc.; Medline Response to Bard Opening Claim Construction Brief; Civil Action No. t:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017. |
Medline Industries Inc. vs OR. Bard, Inc.; Exhibit E to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016. |
Medline Industries Inc. vs C.R Bard, Inc, Exhibit I to C.R. Bard's LPR 2.3 Contentions. Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018. |
Medline Industries Inc. vs C.R Bard, Inc., Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016. |
Medline Industries Inc. vs C.R Bard, Inc., Exhibit 11 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.. Declaration of Kevin A. Lake in Support of Medline Response to Bard Claim Construction Brief: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Barbara Weintraub Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R Bard, inc.; Exhibit D to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief. Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016. |
Medline Industries Inc. vs C.R Bard. Inc.; Exhibit 1 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-036I8; Judge John Z. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc, Exhibit 4 to C.R. Bard's LPR 2 3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018. |
Medline IndustriesfInc. vs C.R. Bard, Inc., Declaration of Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Mar. 23, 2017. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit D lo Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016. |
Medline Industries Inc. vs C.R. Bard. Inc., Exhibit 1 to Declaration of Brian Eutermoser in Support of Medline Surreply; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Sep. 7, 2016. |
Medline Industries Inc. vs C R. Bard, Inc.; Exhibit B to Declaration of Nicole M. Smith; Civil Action No. 1:14˜cv43618; Judge John 2. Lee; Filed Jun. 4, 2016. |
Medline Industries Inc. vs C R. Bard, inc.; Exhibit D to Declaration of Nicole M Smith; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jun. 4, 2016. |
Medline Industries Inc. vs C R. Bard, Inc.; Exhibit E to Declaration oi Nicole M. Smith; Civil Action No. 1:14-cv-03618: Judge John 2. Lee; Filed Jun. 4, 2016. |
Medline Industries Inc. vs C R. Bard, Inc.; Exhibit F to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jun. 4, 2016. |
Medline Industries Inc. vs C R. Bard, Inc; C R. Bard's Opening Claim Construction Bnel; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jun. 4, 2016. |
Medline Industries Inc. vs C R. Bard, inc; C.R Bard's Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Feb. 27, 2018. |
Medline Industries Inc. vs C R. Bard, Inc; Declaration of Dylan Raife in Support of Motion for Leave to Add CounterClaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Eiiis; Filed Feb. 27, 2018. |
Medline Industries Inc. vs C R. Bard, Inc; Exhibit C to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1.17-cv-7216; Judge Sara L. Ellis; Filed Feb. 27, 2018. |
Medline industries Inc. vs C R. Bard. Inc; Exhibit 1 to C R. Bard's LPR 2.3 Contentions, Civil Action No. 1:17-cv-7216, Judge Sara L. Ellis. Filed Jan. 16, 2018. |
Medline Industries Inc. vs C.R Bard, Inc., Exhibit A to Declaration of Richard Meyst re Claim Construction: Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. |
Medline Industries Inc. vs C.R Bard, Inc.; Exhibit B lo Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017. |
Medline Industries Inc. vs C.R. Bard, Inc.; C R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit A—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit B—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit C—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit C to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jun. 4, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit D—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit E—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit F—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit G—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit H—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit I—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit J—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit K—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit L—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit M—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit N—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit O—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit P—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit Q—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit R—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit S—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit T—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. |
Medline Industries Inc. vs C.R. Bard, Inc; C.R. Bard's LPR 3.1 Contentions; Civil Action No. 1:16-cs-3529; Judge Sharon Johnson Coleman; Filed Aug. 26, 2016. |
Medline Industries Inc. vs C.R. Bard, Inc; Exhibit B to C R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018. |
Medline Industries vs. CR Bard, Inc; No. 14-cv-3618; C.R. Bard's LPR 3.1 Contentions; Filed Nov. 24, 2015. |
Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Defendant C.R. Bards, Inc's Second Amended Answer to Second Amended Complaint; Filed Sep. 25, 2015. |
Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Medline Industries Inc's Opposition to C.R.Bard Inc's Motion For Leave to File Second Amended Answer to Add Counterclaim; Filed Oct. 20, 2015. |
Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Medline Industries, Inc.'s Response to C.R. Bard's Initial Invalidity Contentions; Exhibits A-H; Dated Sep. 19, 2014. |
Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Notice of Medline Industries Inc's Motion to Dismiss C.R. Bard Inc's Inequitable Conduct Counterclaim and to strike affirmative defense for the '786 Patent; Filed Oct. 20, 2015. |
Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Response to Medline Industries, Inc.'s First Set of Interrogatories; Dated Sep. 26, 2014. |
Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-3618; Responses to Medline Industries, Inc.'s First set of Requests for the Production of Documents; Dated Sep. 26, 2014. |
Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:17-cv-03618; Medline's Supplemental Responses to Bard's Interrogatory No. 1-24 (redacted), dated Apr. 20, 2016; Filed as IPR Petition Exhibit 2013 in IPR2019-00035 and IPR2019-00036. |
Medline Industries, Inc. vs. C.R. Bard, Inc.; No. 1:17-cv-3539; Medline's Second Supplemental Responses to Bard's Interrogatory No. 11, 14, and 15 (redacted), dated Oct. 26, 2017; Filed as IPR Petition Exhibit 2014 in IPR2019-00035 and IPR2019-00036. |
Medline Industries, Inc. vs. C.R. Bard, Inc.; No. 1:17-cv-7216; Medline's Objection and Response to Bard's First Set of Interrogatories (redacted), dated Oct. 1, 2018; Filed as IPR Petition Exhibit 2012 in IPR2019-00035 and IPR2019-00036. |
Medline Industries, Inc. vs. C.R. Bard, Inc.; No. 14-cv-3618; C.R. Bard's LPR 2.3 Contentions—Initial Non-Infringement; Exhibits 1 and A-H; Dated Sep. 5, 2014. |
Medline Industries, Inc. vs. C.R. Bard, Inc.; No. 14-cv-3618; Memorandum in Support of C.R. Bard's Motion for Leave to File Second Amended Answer to Add Counterclaim; Filed Sep. 25, 2015. |
Medline Industries, Inc. vs. C.R. Bard, Inc.: Transcript of Proceedings—Claim Construction Hearing: Civil Action No. 1:14-cv-3618. Judge John Z. Lee; Dated Jan. 11, 2017. |
Naming Characters on Cards website. URL:<https://web.archive.org/web/20060219171403/http://www.hubbardscupboard.org/brown_bear_brown_bear.html>. (2006) . . . Retrieved form Internet Dec. 11, 2013. |
Notice of Allowance; EP Application No. 10251025.2-1501; Reference P112645EP00; dated Feb. 18, 2016. |
Inter Partes Review—Patent Owner's Prelim. Response; U.S. Pat. No. 9,808,596; Inter Partes Review No. IPR2019-00223; Filed Mar. 7, 2019. |
Medline Industries Inc. vs. C.R Bard, Inc. Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017. |
Webster's Dictionary Definition of “Intend”; Webster's Third New International Dictionary of the English Language unabridged (1961); filed as IPR Petition Exhibit 2016 in IPR 2019-00035. |
“Appeal Decision”, U.S. Appl. No. 12/785,064, filed May 21, 2010; dated May 18, 2016. |
“Article 94(3) EPC Examination”, European Application No. 10 251 025.2-1501; Reference P112645EP00; dated Mar. 13, 2015. |
“Australian First Exam Report”, AU Patent Application No. 2011351971; Patent Examination Report No. 1; dated Jul. 25, 2015. |
“Bard IPR Exhibit”, “Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,631,935; Susan Carrow Declaration; Mailed Dec. 30, 2014. |
“Bard Medical Division Care & Catheterization Script”, Care & Catheterization/Preventing UTI Script for education video; Preventing UTI: Care and Catheterization Techniques; Copyright 2006; AV0512-06R12/05 XXX. |
“Bard Publication”, “A few important words about Catheter Care”; C.R. Bard, Inc.; Copyright 2001 C.R. Bard, Inc. |
“Bardex I.C. Complete Care StateLock Device 350 ml Urine Meter Foley Tray with Bacteriostatic Collection System”, Bard Infection Control System; Bardex I.C. Complete Care Directions for Use; Copyright Dated Sep. 2006. |
“Bardex I.C. Infection Control 350ml Urine Meter Foley Tray”, Bard Infection Control System; Bardex I.C. Urine Meter Foley Tray Directions for Use; Copyright Dated 2006. |
“Bardex I.C. Infection Control Foley Tray”, Bard Infection Control System; Bardex I.C. Directions for Use Infection Control Foley Tray; Copyright Dated 2006. |
“Decision Instituting Inter Partes Review”, IPR2019-00035; U.S. Pat. No. 9,745,088; Mailed Apr. 10, 2019. |
“Decision Instituting Inter Partes Review”, IPR2019-00036; U.S. Pat. No. 9,745,088; Mailed Apr. 10, 2019. |
“Decision Instituting IPR”, IPR 2019-00208; U.S. Pat. No. 9,808,400; Dated Jun. 6, 2019. |
“Decision Instituting Review”, IPR 2019-00223; U.S. Pat. No. 9,808,596; Dated Jun. 6, 2019. |
“EPO Intent to Grant”, EPO Application No. 10251024.5; Filed Jun. 2, 2010; dated Nov. 2, 2012. |
“Examiner's Answer”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; dated Dec. 17, 2013. |
“Expert Report of Barbara Weintraub”, Civil Action No. 1:14-cv-03618; Confidential Information Redacted Pursuant to Court Order; Dated Jun. 14, 2019. |
“Expert Report of Barbara Weintraub”, Civil Action No. 1:16-cv-03529; Confidential Information Redacted Pursuant to Court Order; Dated Aug. 1, 2019. |
“Expert Report of Dr. Edward Yun”, Civil Action No. 1:14-cv-03618; Confidential Information Redacted Pursuant to Court Order; Dated Jun. 13, 2019. |
“Expert Report of Dr. Edward Yun”, Civil Action No. 16-cv-3529; Confidential Information Redacted Pursuant to Court Order; Dated Aug. 1, 2019. |
“Expert Report of Dr. Edward Yun Related to Damages, Non-Infringement, and New Evidence of Alleged Secondary Considerations”, Civil Action No. 1:14-cv-03618; Confidential Information Redacted Pursuant to Court Order; Dated Jul. 23, 2019. |
“Expert Report of Dr. John Abraham”, Civil Action No. 1:14-cv-03618; Confidential Information Redacted Pursuant to Court Order; Dated Jun. 14, 2019. |
“Expert Report of Dr. John Abraham”, Civil Action No. 1:16-cv-03529; Confidential Information Redacted Pursuant to Court Order; Dated Aug. 1, 2019. |
“Expert Report of Dr. Steven Brooks”, Civil Action No. 14-cv-3618; Confidential Information Redacted Pursuant to Court Order; Dated Jul. 25, 2019. |
“Expert Report of Karl R Leinsing, MSME, PE Regarding Alleged Evidence of Secondary Considerations”, Civil Action No. 1:14-cv-3618; Confidential Information Redacted Pursuant to Court Order; Dated Jun. 14, 2019. |
“Expert Validity Report of Dr. John Abraham”, Civil Action No. 1:14-cv-03618; Confidential Information Redacted Pursuant to Court Order; Dated Jul. 25, 2019. |
“Extended EPO Exam Report”, EPO App No. 10251025.2; Filed Jun. 2, 2010; dated Dec. 17, 2013. |
Medline Industries, Inc. vs. C.R. Bard, Inc.; Exhibit J to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jun. 4, 2016. |
“Instructions”, Naming a character website. URL: <https://web.archive.org/web/20080410122058/http://www.wilihow.com/Make-Your-Own-Anime-or-Mange-Character>. 2008. Retrieved from Internet Dec. 10, 2013. |
“Intent to Grant”, Chinese Application No. 201180066491.4; Filed Dec. 30, 2011; dated Jul. 6, 2016. |
“Intent to Grant”, European Application No. 16177903.8-1501; Reference No. SJG/P112645EP02; dated Sep. 18, 2017. |
“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,631,935; Inter Partes Review No. IPR2015-00513; Filed Apr. 21, 2015. |
“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,448,786; IPR2015-00509; Filed Apr. 22, 2015. |
“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,631,935; Inter Partes Review No. IPR2015-00511; Filed Apr. 22, 2015. |
“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,678,190; Inter Partes Review No. IPR2015-00514; Filed Apr. 21, 2015. |
“Inter Partes Review—Patent Owner's Prelim Response”, U.S. Pat. No. 9,745,088; Inter Partes Review No. IPR2019-00035; Filed Jan. 11, 2019. |
“Inter Partes Review—Patent Owner's Prelim Response”, U.S. Pat. No. 9,745,088; Inter Partes Review No. IPR2019-00036; Filed Jan. 11, 2019. |
“Inter Partes Review No. IPR2019-00109”, Petition for Review; U.S. Pat. No. 9,795,761; Filed Oct. 24, 2018. |
“Inter Partes Review Petition”, Exhibit—Amendment filed on Apr. 3, 2013 for U.S. Appl. No. 12/495,148, filed Jun. 30, 2009. |
“Inter Partes Review Petition”, Exhibit—Bard DFU; Bardex Infection Control Foley Tray; Copyright 2006, publication date unknown. |
“Inter Partes Review Petition”, Exhibit—Bardex DFU; Directions for Use/Patient Education Information—Urology; Unknown Publication Date. |
“Inter Partes Review Petition”, Exhibit—Declaration of Susan Carrow for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Mailed Dec. 30, 2014. |
“Inter Partes Review Petition”, Exhibit—EC Guideline 1998; “A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use”; Published Sep. 29, 1998 (Sep. 29, 1998); Mailed Dec. 30, 2014. |
“Inter Partes Review Petition”, Exhibit—Health Protection Scotland; CAUTI Maintenance Bundel; Version 2, Feb. 2008. |
“Inter Partes Review Petition”, Exhibit—Infection Control Today Article; Medical Center Cuts Catheterizations by 21 Percent with Foley Catheter Management System; Published 2010. |
“Inter Partes Review Petition”, Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014. |
“Inter Partes Review Petition”, Exhibit—Medical News Today Article; ‘Getting to Zero:’ Medline's' Erase Cauti Program Helps Hospitals Reduce Catheter Use by 20 Percent; Article Date Apr. 13, 2011. |
“Inter Partes Review Petition”, Exhibit—Medline Initial Infringement Contentions; Medline Industries vs. C.R. Bard; Dated Aug. 22, 2014. |
“Inter Partes Review Petition”, Exhibit—Morning Start Article; “Floyd Medical Center Reduces Catheter-Associated Urinary Tract Infections 83 Percent and Catheter Use by 23 Percent”; Published Jan. 2011. |
“Inter Partes Review Petition”, Exhibit—Nursing Standard; Article in Learning Zone—Continue Professional Development; “Reducing the risks associated with urinary catheters”; Published Mar. 25, 2009. |
“Inter Partes Review Petition”, Exhibit—RCE Filed November May 31, 2011 for U.S. Appl. No. 12/495,148, filed Jun. 30, 2009. |
“Inter Partes Review Petition”, Exhibit—Response to Office Action in U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; Response Filed Nov. 19, 2010. |
“Inter Partes Review Petition”, Exhibit—The Journal of Healthcare Contracting, Oct. 2012; “Catheter-associated urinary tract infections”. |
“Inter Partes Review Petition”, Exhibit—Webster's Dictionary Definition of Dispose; Webster's Third New International Dictionary; Copyright 2003; publication date unknown. |
“Inter Partes Review Petition”, Exhibit; Carrow CV—Susan Carrow CV; Mailed Dec. 30, 2014. |
“Inter Partes Review Petition”, Exhibit; EC Guideline 2009; “Guideline on the Readability of the Labeling and Package Leaflet of Medicinal Products for Human Use”; Revision 1 Published Jan. 12, 2009 (Jan. 12, 2009); Mailed Dec. 30, 2014. |
“Inter Partes Review Petition”, Exhibit; Kimmel CV—Dr. Robert M. Kimmel; Mailed Dec. 30, 2014. |
“Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Susan Carrow Declaration; Mailed Dec. 30, 2014. |
“Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,768,190; Declaration of Susan Carrow; Mailed Dec. 30, 2014. |
“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration U.S. Pat. No. 8,448,786 Patent; Dr. Robert M. Kimmel Declaration; Received Dec. 30, 2014. |
“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014. |
“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 7-8, 10, 21-23, 25, 27-28, and 30-34; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014. |
“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,768,190; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014. |
“Inter Partes Review Petition”, IPR Exhibit—Susan Carrow Declaration U.S. Pat. No. 8,448,786 patent; mailed Dec. 30, 2014. |
“Inter Partes Review Petition for U.S. Pat. No. 8,448,786”, U.S. Pat. No. 8,448,786; Filed Dec. 30, 2014; Mailed Dec. 30, 2014. |
“Inter Partes Review Petition for U.S. Pat. No. 8,631,935”, Inter Partes Review Petition for U.S. Pat. No. 8,631,935 for claims 1-4 and 11-20; Filed Dec. 30, 2014. |
“Inter Partes Review Petition for U.S. Pat. No. 8,631,935”, Inter Partes Review Petition for U.S. Pat. No. 8,631,935 for Claims 7-8, 10, 21-23, 25, 27-28, and 30-34; Filed Dec. 30, 2014. |
“Inter Partes Review Petition for U.S. Pat. No. 8,678,190”, Inter Partes Review Petition for U.S. Pat. No. 8,678,190; Filed Dec. 30, 2014. |
“Inter Partes Review Petition for U.S. Pat. No. 9,745,088”, IPR-0036; Filed Oct. 4, 2018. |
“Inter Partes Review Petition for U.S. Pat. No. 9,745,088”, IPR2019-0035, filed Oct. 4, 2018. |
“IPR 2015-00514—Patent Owner's Objection to Evidence”, IPR 2015-00514—Patent Owner's Objection to Evidence Submitted During a Preliminary Proceeding; U.S. Pat. No. 8,678,190; Mailed Jul. 13, 2015. |
“IPR 2015-00514—Patent Owner's Request for Adverse Judgment”, U.S. Pat. No. 8,678,190; Mailed Jul. 23, 2015. |
“IPR 2015-00514—Request for Rehearing Denied”, IPR2015-00514; U.S. Pat. No. 8,678,190; Decision on Request for Rehearing—Denied; Mailed Jul. 16, 2015. |
“IPR 2015-00514 Petitioner's Request for Rehearing”, IPR 2015-00514 Petitioner's Request for Rehearing; U.S. Pat. No. 8,678,190; Dated Jul. 10, 2015. |
“IPR 2019-00109”, Exhibit 1031—Declaration of Jennifer Tomes filed in U.S. Appl. No. 12/647,515 dated Dec. 7, 2012. |
“IPR 2019-00109”, U.S. Pat. No. 9,795,761; Filed Oct. 24, 2018; Declaration of Dr. Edward Yun. |
“IPR Decision Instituting Inter Partes Review”, IPR2019-00109; U.S. Pat. No. 9,795,761; Mailed May 6, 2019. |
“IPR Exhibit 1002”, Declaration of Pliska; IPR2019-0035, Filed Oct. 4, 2018. |
“IPR Exhibit 1003”, Declaration of Yun; IPR2019-0035; Filed Oct. 4, 2018. |
“IPR Exhibit 1022”, Email from Medline counsel re claims constructions; IPR2019-0035; Filed Oct. 4, 2018. |
“IPR Petition Exhibit 1016”, Excerpt from “The Design of Everyday Things”; IPR2019-0035; Filed Oct. 4, 2018. |
“IPR Petition Exhibit 1024”, Email from Bard counsel re claims constructions; IPR2019-0035; Filed Oct. 4, 2018. |
“IPR0215-00513 Scheduling Order”, U.S. Pat. No. 8,631,935; Mailed Jul. 15, 2015. |
“IPR2015-00509 Institution Decision”, IPR2015-00509; U.S. Pat. No. 8,448,786; Mailed Jul. 15, 2015; Decision Denying Institution of Inter Partes Review. |
“IPR2015-00511 Institution Decision”, IPR2015-00511; U.S. Pat. No. 8,631,935; Entered Jul. 15, 2015; Decision Denying Institution of Inter Partes Review. |
“IPR2015-00513—Request for Adverse Judgment”, IPR2015-00513—Request for Adverse Judgment; Granted—Proceedings Terminated; U.S. Pat. No. 8,631,935; Entered Aug. 11, 2015. |
“IPR2015-00513—Patent Owner's Request for Adverse Judgment”, U.S. Pat. No. 8,631,935; Mailed Jul. 23, 2015. |
“IPR2015-00513 Institution Decision”, IPR2015-00513 Institution Decision; U.S. Pat. No. 8,631,935; Entered Jul. 15, 2015; Decision Institution of Inter Partes Review. |
“IPR2015-00514—Scheduling Order”, U.S. Pat. No. 8,678,190; Mailed Jun. 26, 2015. |
“IPR2015-00514 Decision Institution of Inter Partes Review”, IPR2015-00514; U.S. Pat. No. 8,678,190; Mailed Jun. 26, 2015; Decision Institution of Inter Partes Review. |
“IPR2015-00514 Judgment—Termination of Proceeding”, U.S. Pat. No. 8,678,190; Mailed Jul. 24, 2015. |
“IPR2019-00109”, Exhibit 1026—Bard's Opening Claim Construction Brief; Civil Action No. 1:17-cv-07216; Dated Oct. 10, 2018; Filed Oct. 24, 2018 as exhibit 1026. |
“IPR2019-00109”, Exhibit 1030—Medline Industries, Inc.'s Final Infringement Contentions; Filed Jul. 24, 2018 in Civil Action No. 1:17-cv-07216; Filed as exhibit Oct. 24, 2018. |
“IPR2019-00109”, U.S. Pat. No. 9,795,761; Filed Oct. 24, 2018; Exhibit 1002 Declaration of Michael Plishka. |
“Markman Decision”, Medline Industries, Inc. vs. C.R. Bard, Inc.; Case No. 1:16-cv-03529\; Memorandum Opinion and Order; Judge Sharon Johnson Coleman Issued Dec. 28, 2018. |
“Markman Hearing”, Medline Industries, Inc. vs. C.R. Bard, Inc.; Case No. 1:17-cv-07216; Memorandum Opinion and Order; Judge Sara L. Ellis; Issued Jan. 28, 2019. |
“NonFinal Office Action”, U.S. Appl. No. 13/680,902, filed Apr. 11, 2014; dated Dec. 2, 2014. |
“Notice of Acceptance”, Australian Application No. 2011351971; Filed Dec. 30, 2011; dated May 13, 2016. |
“Notice of Allowance”, Canadian Application No. 2,705,647; Filed May 27, 2010; dated Oct. 12, 2017. |
“Notice of Allowance”, Canadian Application No. 2,705,670; dated Nov. 3, 2017. |
“Notice of Allowance”, Chinese Application No. 201280035240.4; dated Nov. 7, 2017. |
“Office Action”, Australian Application No. 2011351971; Reference No. 35204298/GP; dated Feb. 18, 2016. |
“Office Action”, Chinese Application No. 201180066491.4; dated Mar. 24, 2015. |
“Office Action”, Chinese Application No. 201180066491.4; dated Nov. 11, 2015. |
“Office Action”, Chinese Application No. 201280035246.1; Filed May 11, 2012; dated Jul. 15, 2016. |
“Office Action”, Chinese Application No. 201280035246.1; Filed May 11, 2012; dated Nov. 28, 2016. |
“Office Action Received”, Chinese App No. 201280035246.1; NonFinal OA; dated Sep. 16, 2015. |
“Opening Expert Report of Karl R Leinsing, MSME, PE”, Civil Action No. 1:14-cv-3618; Confidential Information Redacted Pursuant to Court Order; Dated Jun. 14, 2019. |
“Opening Expert Report of Karl R. Leinsing, MSME, PE”, Civil Action No. 1:16-cv-3529; Confidential Information Redacted Pursuant to Court Order; Dated Aug. 1, 2019. |
“Petition for Inter Partes Review”, IPR 2019-00208; U.S. Pat. No. 9,808,400; Filed Nov. 7, 2018. |
“Petition for Inter Partes Review”, IPR 2019-00223; U.S. Pat. No. 9,808,596; Filed Nov. 7, 2018. |
“Publication”, European Commission: Pharmaceutical Committee “A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use”; Dated Sep. 29, 1998. |
“Rebuttal Expert Report of Barbara Weintraub”, Civil Action No. 1:14-cv-03618; Confidential Information Redacted Pursuant to Court Order; Dated Jul. 25, 2019. |
“Rebuttal Expert Report of Richard Hillstead, PH.D.”, Civil Action No. 1:14-cv-3618; Confidential Information Redacted Pursuant to Court Order; Dated Jun. 14, 2019. |
“Second Office Action”, Chinese Application No. 201280035240.4; dated Jun. 23, 2016. |
“Third Office Action”, Chinese Application No. 201280035240.4; dated Apr. 1, 2017. |
Byun, Sung C.“PCT Search Report”, PCT/US2011/068193; Filed Dec. 30, 2011; dated Aug. 22, 2012. |
Byun, Sung C.“PCT Search Report”, PCT/US2012/039311; Filed May 24, 2011; dated Oct. 25, 2012. |
Byun, Sung Cheal, “PCT Search Report and Written Opinion”, PCT/US2012/037524; Filed May 11, 2012; dated Nov. 16, 2012. |
Cavanna, Mark, “Ex Parte Quayle Action”, U.S. Appl. No. 29/380,474, filed Dec. 6, 2010; Mailed Aug. 14, 2012. |
Cavanna, Mark, “Final OA”, U.S. Appl. No. 29/479,600, filed Jan. 17, 2014; dated Jun. 1, 2017. |
Cavanna, Mark, “NonFinal OA”, U.S. Appl. No. 29/479,600, filed Jan. 17, 2014; dated Jan. 3, 2018. |
Cavanna, Mark, “NonFinal Office Action”, U.S. Appl. No. 29/380,474, filed Dec. 26, 2012; dated Mar. 27, 2012. |
Cavanna, Mark, “Non-Final Office Action”, U.S. Appl. No. 29/479,600; filed Jan. 17, 2014; dated Sep. 26, 2016. |
Cavanna, Mark, “Notice of Allowance”, U.S. Appl. No. 29/338,022, filed Jun. 3, 2009; dated Oct. 1, 2009. |
Cavanna, Mark, “Notice of Allowance”, U.S. Appl. No. 29/362,279, filed May 21, 2010, dated Sep. 19, 2011. |
Cavanna, Mark, “Notice of Allowance”, U.S. Appl. No. 29/444,526, filed Jan. 31, 2013; dated Oct. 17, 2013. |
European Patent Office, “Extended EPO Search Report”, Application No. 10251024.5, In the Name of Medline Industries, dated Oct. 18, 2010. |
European Patent Office, “Extended EPO Search Report”, EPO Application No. 10251025.2, In the Name of Medline Industries, dated Sep. 29, 2010. |
Examiner, Chinese Patent Office, “First Office Action”, CN Application No. 201020219785.9; dated Nov. 18, 2010; Filed Jun. 3, 2010. |
Gilligan, C. Luke, “Notice of Allowance”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; dated Jun. 15, 2017. |
Gimenez Burgos, R, “European Examination Report”, European Application No. 11 854 003.8-1659; Ref SJG/P128064EP00; dated Jan. 22, 2015. |
Gimenez Burgos, R, “Extended European Search Report”, 11854003.8; Filed Dec. 30, 2011; dated Jun. 3, 2014. |
Gimenez Burgos, R, “Extended European Search Report”, EPO App No. 12 79 3939; Reference No. SJG/P130269EP00; dated Jan. 27, 2015. |
Gimenez Burgos, R, “Extended European Search Report”, EU App No. 12792423.1-1659/2713933; PCT/US2012039311; Reference No. SJG/P130270EP00; dated Jan. 27, 2015. |
Hand, Melanie J., “Final OA”, U.S. Appl. No. 12/785,064, filed May 21, 2010; dated Jun. 5, 2013. |
Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 12/785,064, filed May 21, 2010; dated Feb. 1, 2013. |
Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 13/115,053, filed Jun. 7, 2011; dated May 9, 2013. |
Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 13/155,026, filed Jun. 7, 2011; dated Nov. 30, 2012. |
Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; dated Apr. 1, 2016. |
Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 14/165,044, filed Jan. 27, 2014; dated Oct. 26, 2015. |
Hand, Melanie J., “Notice of Allowance”, U.S. Appl. No. 13/155,026, filed Jun. 7, 2011; dated Feb. 1, 2013. |
Hand, Melanie J., “Notice of Allowance”, U.S. Appl. No. 13/155,054, filed Jun. 7, 2011; dated Oct. 28, 2013. |
Hand, Melanie J., “Notice of Allowance”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; dated Aug. 4, 2015. |
Hand, Melanie Jo, “Appeal Decision”, U.S. Appl. No. 12/785,064, filed May 21, 2010; dated May 18, 2016. |
Hand, Melanie Jo, “Final OA”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; dated May 22, 2015. |
Klein, Benjamin J., “NonFinal OA”, U.S. Appl. No. 15/5051,964, filed Feb. 24, 2016; dated Jan. 7, 2019. |
Klein, Benjamin Jacob, “Notice of Allowance”, U.S. Appl. No. 15/051,964, filed Feb. 24, 2016; dated Aug. 21, 2019. |
Lawrence, Samantha Q., “Notice of Allowance”, U.S. Appl. No. 29/479,600, filed Jan. 17, 2014; dated Apr. 25, 2019. |
Long, Fonya M, “Appeal Decision”, U.S. Appl. No. 13/154,265, filed Jun. 3, 2011; dated Oct. 6, 2016. |
Mackenzie, Kristian, “Office Action”, Canadian Application No. 2,705,647; Ref No. 15486-P37235CA00; dated Feb. 10, 2017. |
Mackenzie, Kristian, “Office Action”, Canadian Application No. 2,705,647; Ref No. 15468-P37235CA00; dated Apr. 21, 2016. |
Mackenzie, Kristian, “Office Action”, Canadian Application No. 2,705,670; Attorney Ref No. 15468-P37238CA00; dated Feb. 10, 2017. |
Mackenzie, Kristian, “Office Action”, Canadian Application No. 2,705,670; Ref No. 15468-8; dated Apr. 25, 2016. |
Marcetich, Adam, “Non-Final OA”, U.S. Appl. No. 15/640,224, filed Jun. 30, 2017; dated Jul. 10, 2019. |
Marcetich, Adam, “NonFinal Office Action”, U.S. Appl. No. 15/684,787, filed Aug. 23, 2017; dated Nov. 4, 2019. |
Marcetich, Adam, “Notice of Allowance”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; dated Nov. 8, 2016. |
Marcetich, Adam, “Notice of Allowance”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; dated Sep. 14, 2016. |
Marcetich, Adam, “Notice of Allowance”, U.S. Appl. No. 14/165,044, filed Jan. 27, 2014; dated Feb. 28, 2017. |
Marcetich, Adam, “Notice of Allowance”, U.S. Appl. No. 14/793,455, filed Jul. 7, 2015; dated Jul. 20, 2017. |
Marcetich, Adam M., “Final OA”, U.S. Appl. No. 14/165,044, filed Jan. 27, 2014; dated Aug. 11, 2016. |
Marcetich, Adam M., “Notice of Allowance”, U.S. Appl. No. 15/640,224, filed Jun. 30, 2017; dated Nov. 21, 2019. |
Marcitech, Adam, “NonFinal OA”, U.S. Appl. No. 14/793,455, filed Jul. 7, 2015; dated May 3, 2017. |
Medline, “Medline Article/Brochure”, Published 2008. |
Mian, Ali, “Non-Final Office Action”, Canadian Application No. 2,837,324; dated Oct. 3, 2018. |
Mian, Ali, “Office Action”, Canadian Application No. 2,837,324; dated Sep. 3, 2019. |
Ortega, Rafael et al., “Female Urethral Catheterization”, N. Engl. J. Med vol. 358:e15; published 2008. |
Pass, Natalie, “Final OA”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; dated Jul. 12, 2013. |
Pass, Natalie, “NonFinal OA”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; dated Mar. 5, 2013. |
Poon, Robert, “Appeal Decision”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated Jan. 19, 2018. |
Poon, Robert, “Appeal Decision”, U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; dated Oct. 12, 2016. |
Poon, Robert, “Appeal Decision”, U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; dated Oct. 24, 2016. |
Poon, Robert, “Appeal Decision”, U.S. Appl. No. 14/265,920, filed Apr. 30, 2014; dated Aug. 1, 2018. |
Poon, Robert, “Final OA”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated Apr. 7, 2015. |
Poon, Robert, “Final OA”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated May 13, 2013. |
Poon, Robert, “Final OA”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Dec. 18, 2013. |
Poon, Robert, “Final OA”, U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; dated Aug. 6, 2013. |
Poon, Robert, “Final OA”, U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; dated Aug. 6, 2013. |
Poon, Robert, “Final OA”, U.S. Appl. No. 14/265,909, filed Apr. 30, 2014; dated Jan. 10, 2017. |
Poon, Robert, “Final OA”, U.S. Appl. No. 14/265,909, filed Apr. 30, 2015; dated Oct. 5, 2015. |
Poon, Robert, “Final OA”, U.S. Appl. No. 14/265,920, filed Apr. 30, 2014; dated Oct. 2, 2015. |
Poon, Robert, “Final OA”, U.S. Appl. No. 14/718,792, filed May 21, 2015; dated Jan. 5, 2016. |
Poon, Robert, “Final OA”, U.S. Appl. No. 15/067,903, filed Mar. 11, 2016; dated Jan. 13, 2017. |
Poon, Robert, “Final Office Action”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009, dated Mar. 3, 2011. |
Poon, Robert, “Final Office Action”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; dated Jul. 31, 2013. |
Poon, Robert, “Final Office Action”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Sep. 26, 2012. |
Poon, Robert, “Final Office Action”, U.S. Appl. No. 14/718,912, filed May 21, 2015; dated Jan. 5, 2016. |
Poon, Robert, “Final Office Action”, U.S. Appl. No. 15/703,514, filed Sep. 13, 2017; dated May 2, 2019. |
Poon, Robert, “Final Office Action”, U.S. Appl. No. 15/703,514; dated May 2, 2019. |
Poon, Robert, “Final Office Action”, U.S. Appl. No. 15/803,383, filed Nov. 3, 2017; dated Jul. 25, 2019. |
Poon, Robert, “Final Office Action”, U.S. Appl. No. 15/804,520, filed Nov. 6, 2017; dated Aug. 8, 2019. |
Poon, Robert, “NonFinal OA”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; dated Oct. 4, 2012. |
Poon, Robert, “NonFinal OA”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated Dec. 18, 2013. |
Poon, Robert, “NonFinal OA”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Sep. 10, 2013. |
Poon, Robert, “NonFinal OA”, U.S. Appl. No. 14/265,909, filed Apr. 30, 2014; dated Sep. 12, 2016. |
Poon, Robert, “NonFinal OA”, U.S. Appl. No. 14/265,909, filed Apr. 30, 2014; dated Dec. 31, 2014. |
Poon, Robert, “NonFinal OA”, U.S. Appl. No. 14/265,920, filed Apr. 30, 2014; dated Dec. 30, 2014. |
Poon, Robert, “NonFinal OA”, U.S. Appl. No. 14/718,792, filed May 21, 2015; dated Nov. 19, 2015. |
Poon, Robert, “NonFinal OA”, U.S. Appl. No. 15/067,903, filed Mar. 11, 2016; dated Jun. 30, 2016. |
Poon, Robert, “NonFinal OA”, U.S. Appl. No. 15/803,383, filed Nov. 3, 2017; dated Mar. 7, 2018. |
Poon, Robert, “NonFinal OA”, U.S. Appl. No. 15/804,520, filed Nov. 6, 2017; dated Jan. 19, 2018. |
Poon, Robert, “Non-Final OA”, U.S. Appl. No. 14/265,909, filed Apr. 30, 2014; dated Aug. 24, 2017. |
Poon, Robert, “NonFinal Office Action”, U.S. Appl. No. 15/703,514, filed Sep. 13, 2017; dated Jun. 22, 2018. |
Poon, Robert, “NonFinal Office Action”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated Jun. 28, 2012. |
Poon, Robert, “NonFinal Office Action”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Dec. 22, 2011. |
Poon, Robert, “NonFinal Office Action”, U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; dated Oct. 1, 2012. |
Poon, Robert, “NonFinal Office Action”, U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; dated Oct. 2, 2012. |
Poon, Robert, “NonFinal Office Action”, U.S. Appl. No. 15/804,520, filed Nov. 6, 2017; dated Jun. 6, 2018. |
Poon, Robert, “NonFinal Office Action”, U.S. Appl. No. 16/258,231, filed Jan. 25, 2019; dated Oct. 2, 2019. |
Poon, Robert, “Non-Final Office Action”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; first inventor: Jennifer E. Tomes; dated Aug. 4, 2010. |
Poon, Robert, “Non-Final Office Action”, U.S. Appl. No. 15/803,393, filed Nov. 3, 2017; dated Oct. 15, 2018. |
Poon, Robert, “Non-Final Office Action”, U.S. Appl. No. 15/804,520, filed Nov. 6, 2017; dated Nov. 2, 2018. |
Poon, Robert, “Notice of Allowance”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; dated Nov. 20, 2013. |
Poon, Robert, “Notice of Allowance”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Apr. 30, 2014. |
Poon, Robert, “Notice of Allowance”, U.S. Appl. No. 14/265,920, filed Apr. 30, 2014; dated Nov. 28, 2018. |
Poon, Robert, “Notice of Allowance”, U.S. Appl. No. 14/718,792, filed May 21, 2015; dated Feb. 2, 2016. |
Poon, Robert, “Notice of Allowance”, U.S. Appl. No. 14/265,909, fFiled Apr. 30, 2014; dated Oct. 2, 2017. |
Poon, Robert, “Notice of allowance”, U.S. Appl. No. 15/067,903, filed Mar. 11, 2016; dated Aug. 23, 2017. |
Poon, Robert, “Restriction Requirement”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated May 23, 2012. |
Pothier, Andrew, “NonFinal OA”, Canadian Application No. 2,837,289; dated Feb. 14, 2018. |
Pothier, Andrew, “NonFinal Office Action”, Canadian Patent Application No. 2,822,905; Reference No. 15468-P44352CA00; dated Aug. 31, 2018. |
Pothier, Andrew, “Non-Final Office Action”, Canadian Application No. 2,837,289; dated Jun. 27, 2019. |
Pothier, Andrew, “Non-Final Office Action”, Canadian Application No. 2,822,905; File No. 15468-P44352CA00; dated Dec. 18, 2017. |
Pothier, Andrew, “Office Action”, Canadian Application No. 2,822,905; dated Jun. 13, 2019. |
Pothier, Andrew, “Office Action”, Canadian Application No. 2,822,905; Reference No. 15468-P44352CA00; dated May 1, 2017. |
Pothier, Andrew, “Office Action”, Canadian Application No. 2,837,289; dated Oct. 29, 2018. |
Power, “Postoperative behavior changes and pain in children, 2 to 12 years, following inpatient and day case surgery”, University College London; http://discovery.ucl.ac.uk/643438/1/643438.pdf, Aug. 2010. |
Prange, Sharon M., “Response to First Office Action”, U.S. Appl. No. 12/004,796, filed Dec. 21, 2007; dated Oct. 28, 2009. |
Schultz, Ottmar, “Extended European Search Report”, EP Application No. 16177903.8-1501; Filed Jun. 30, 2009; dated Oct. 27, 2016. |
Thomsen, Todd, “Male Urethral Catheterization”, N. Engl. J. Med vol. 354:e22; Published 2006. |
Van Poelgeest, A, “Exam Report”, EP Application No. 12792423.1; dated Sep. 17, 2019. |
Van Poelgeest, A, “Exam Report”, European Application No. 12793939.5; dated Oct. 7, 2019. |
Van Poelgeest, A, “Examination Report”, EP Application No. 11 854 003.8-1113; Sep. 17, 2019. |
Vasat, Peter, “NonFinal OA”, U.S. Appl. No. 12/785,064, filed May 21, 2010; dated Feb. 9, 2018. |
Vasat, Peter, “Notice of Allowance”, U.S. Appl. No. 12/785,064, filed May 21, 2010; dated Sep. 12, 2016. |
Yuan, Minqiang, “Non-Final Office Action”, Chinese Application No. 200920267201.2, dated Sep. 9, 2010. |
Yuan, Minquiang, “Non-Final Office Action”, Chinese Application No. 200920267201.2, dated Jun. 4, 2010. |
Zeev, et al., “Family-centered Preparation for Surgery Improves Perioperative Outcomes in Children: A randomized Controlled Trial”, Anesthesiology, 106, pp. 65-74; https://anesthesiology.pubs.asahq.org/article.aspx?articleid=1922803 ; Jan. 2007. |
Lawrence, Samantha , “Notice of Allowance”, U.S. Appl. No. 29/479,600, filed Jan. 17, 2014; dated Feb. 24, 2020. |
Marcetich, Adam , “Notice of Allowance”, U.S. Appl. No. 15/684,787, filed Aug. 23, 2017; dated Feb. 27, 2020. |
Poon, Robert , “NonFinal Office Action”, U.S. Appl. No. 15/703,514, filed Sep. 13, 2017; dated Mar. 17, 2020. |
Poon, Robert , “Non-Final Office Action”, U.S. Appl. No. 15/803,383, filed Nov. 3, 2017; dated Mar. 16, 2020. |
“Final Written Decision”, IPR 2019-00109; dated May 4, 2020; U.S. Pat. No. 9,795,761. |
“Final Written Decision”, IPR 2019-00208; U.S. Pat. No. 9,808,400; Entered Jun. 3, 2020. |
“Final Written Decision”, IPR 2019-00223; U.S. Pat. No. 9,808,596; Entered Jun. 3, 2020. |
Pothier, Andrew , “Office Action”, Canadian Application No. 2,837,289; dated Feb. 27, 2020. |
Pothier, Andrew , “Office Action”, Canadian Application No. 2822905; dated Feb. 27, 2020. |
“Final Written Decision”, IPR 2019-00035; U.S. Pat. No. 9,745,008; Entered Apr. 8, 2020. |
“Final Written Decision”, IPR 2019-00036; U.S. Pat. No. 9,745,008; Entered Apr. 8, 2020. |
“Summons to Attend Oral Proceedings”, EP Application 11854003.8; Mailed Dec. 22, 2020. |
“Summons to Attend Oral Proceedings”, EP Application 12792423.1; Mailed Dec. 22, 2020. |
“Summons to Attend Oral Proceedings”, EP Application 12793939.5; Mailed Dec. 23, 2020. |
Arble, Jessica , “Final OA”, U.S. Appl. No. 15/977,944, filed May 11, 2018; dated Aug. 5, 2020. |
Arble, Jessica , “NonFinal Office Action”, U.S. Appl. No. 15/977,944, filed May 11, 2018; dated Apr. 28, 2020. |
Arble, Jessica , “NonFinal Office Action”, U.S. Appl. No. 15/977,944, filed May 11, 2018; dated Feb. 3, 2021. |
Arble, Jessica , “Notice of Allowance”, U.S. Appl. No. 15/977,944, filed May 11, 2018; dated Aug. 17, 2021. |
Poon, Robert , “NonFinal Office Action”, U.S. Appl. No. 16/258,231, filed Jan. 25, 2019; dated Mar. 31, 2021. |
Poon, Robert , “Notice of Allowance”, U.S. Appl. No. 15/703,514, filed Sep. 13, 2017; dated Nov. 23, 2020. |
Poon, Robert , “Notice of Allowance”, U.S. Appl. No. 15/803,383, filed Nov. 3, 2017; dated Nov. 27, 2020. |
Poon, Robert , “Final Office Action”, U.S. Appl. No. 16/258,231, filed Jan. 25, 2019; dated Jul. 15, 2020. |
C. R. Bard, Inc. v. Medline Industries, Inc., 2020-1900, 2020-1905, 2020-1908, 2020-1910 Slip Opinion (Fed. Cir. 2021). Dated Aug. 13, 2021. |
JP2000281144-A Machine translation Oct. 17, 2022; Cited in U.S. Appl. No. 16/721,718 on Oct. 26, 2022. |
JP2002068309-A Machine translation Oct. 17, 2022; Cited in U.S. Appl. No. 16/721,718 on Oct. 26, 2022. |
“Ex Parte Reexamination Request”, Reexmination Control No. 90/015,051 for U.S. Pat. No. 9,522,753; Mailed Jun. 28, 2022; Request and Exhibits 1-28. |
“Request for Ex Parte Reexamination”, Reexam Control No. 90/014,964 for U.S. Pat. No. 8,448,786; Mailed Mar. 8, 2022; Request and Exhibits 1-35. |
Klein, Benjamin , “Non-Final Office Action”, U.S. Appl. No. 16/688,185, filed Nov. 19, 2019; dated Jan. 31, 2023. |
Marcetich, Adam , “NonFinal Office Action”, U.S. Appl. No. 16/833,575, filed Mar. 28, 2020; dated Sep. 13, 2022. |
Marcetich, Adam M. , “Notice of Allowance”, U.S. Appl. No. 16/721,718, filed Dec. 19, 2019; dated Oct. 26, 2022. |
Marcetich, Adam M. , “Notice of Allowance”, U.S. Appl. No. 16/721,718, filed Dec. 19, 2019; dated Feb. 9, 2023. |
Poon, Robert , “Final Office Action”, U.S. Appl. No. 16/258,231, filed Jan. 25, 2019; dated Oct. 7, 2021. |
Poon, Robert , “Final Office Action”, U.S. Appl. No. 16/986,803, filed Aug. 6, 2020; dated Jul. 5, 2022. |
Poon, Robert , “Final Office Action”, U.S. Appl. No. 17/180,680, filed Feb. 19, 2021; dated Sep. 16, 2022. |
Poon, Robert , “NonFinal Office Action”, U.S. Appl. No. 17/835,747, filed Jun. 8, 2022; dated Oct. 12, 2022. |
Poon, Robert , “Non-Final Office Action”, U.S. Appl. No. 17/180,680; dated Dec. 22, 2021. |
Reip, David O. , “Re-Exam Non-Final Office Action”, U.S. Appl. No. 90/015,051, filed Jun. 8, 2022; dated Dec. 14, 2022. |
Reip, David Owen , “Ex Parte Reexamination Order—Request Granted”, Reexam Control No. 90/014,964 for U.S. Pat. No. 8,448,786; Mailed Apr. 19, 2022. |
Reip, David Owen , “Ex Parte Reexamination Order—Request Granted”, Reexmination Control No. 90/015,051 for U.S. Pat. No. 9522753; Mailed Jul. 7, 2022. |
Reip, David Owen , “Reexam NonFinal Office Action”, U.S. Appl. No. 90/014,964, filed Feb. 24, 2022; dated Sep. 29, 2022. |
Marcetich, Adam, “Notice of Allowance”, U.S. Appl. No. 16/833,575, filed Mar. 28, 2020; dated Feb. 24, 2023. |
Reip, David O., “Notice of Intent to Issue Ex Parte Reexam Certificate”, U.S. Appl. No. 90/014,964; Patent Under Reexam U.S. Pat. No. 8,448,786; dated Mar. 21, 2023. |
Reip, David O., “ReExamination Final Office Action”, U.S. Appl. No. 90/015,051; filed Jun. 8, 2022; Patent Under Reexam U.S. Pat. No. 9,522,753; dated Apr. 4, 2023. |
Number | Date | Country | |
---|---|---|---|
20200385153 A1 | Dec 2020 | US |
Number | Date | Country | |
---|---|---|---|
61352140 | Jun 2010 | US | |
61352155 | Jun 2010 | US | |
61428944 | Dec 2010 | US | |
61437796 | Jan 2011 | US | |
61183629 | Jun 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13155026 | Jun 2011 | US |
Child | 13860902 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16833575 | Mar 2020 | US |
Child | 16944667 | US | |
Parent | 15684787 | Aug 2017 | US |
Child | 16833575 | US | |
Parent | 14793455 | Jul 2015 | US |
Child | 15684787 | US | |
Parent | 13860902 | Apr 2013 | US |
Child | 14793455 | US | |
Parent | 12495148 | Jun 2009 | US |
Child | 13155026 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12647515 | Dec 2009 | US |
Child | 12495148 | US | |
Parent | 13153265 | Jun 2011 | US |
Child | 12647515 | US | |
Parent | 13153300 | Jun 2011 | US |
Child | 13153265 | US |